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ABSTRACT

Polycyclic aromatic hydrocarbons (PAHs), are known immunotoxicants in animals,
and are suspect toxins to the human immune system. The mechanism(s), however, by
which PAHs exert immunosuppression have not been fully elucidated. Previous studies
conducted in our laboratory have shown that PAHs, such as 7,12-dimethylbenz(a)anthracene (DMB A) and benzo(a)pyrene (BaP) may exert their immunotoxic effects by
altering intracellular calcium (Ca2+) homeostasis in lymphocytes. Intracellular Ca2+ is an
important second messenger in the immune response, and the mobilization of Ca2+ is
critical in the transduction of intracellular signals from the plasma membrane to the
nucleus. The overall objective of this project was to examine the effects o f PAHs on
intracellular Ca2+ levels in human immune cells, particularly B lymphocytes. In these
studies, it was shown that highly immunosuppressive PAHs, such as DMBA and BaP,
produced a time-dependent increase in intracellular Ca2+ in normal human peripheral blood
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B cells, T cells, and monocytes. Benzo(e)pyrene (BeP) and anthracene, however, did not
produce a statistically significant elevation in intracellular Ca2+. While studies have shown
that certain PAHs, such as DMBA and BaP, exert their immunomodulatory effects
directly, other researchers have shown that PAH-induced immunotoxicity may be
mediated by the reactive metabolites of PAHs. Our laboratory has previously shown that
the suppression o f T cell mitogenesis produced by PAHs and certain BaP metabolites is
reversed by treatment with the cytochrome P450 inhibitor, a-naphthoflavone. Therefore,
a second objective in this research was to evaluate the potential role of cytochrome 450
and certain BaP metabolites in PAH-induced Ca2+ elevation in human B lymphocytes.
Both of the BaP metabolites examined, BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide, were
more potent in producing an elevation in free intracellular Ca2+ than the parent compound.
Additionally, the Ca2+ elevation produced by BaP-7,8-diol was completely blocked by
pretreatment with ANF, suggesting a role for P450 activation. ANF had no effect on the
Ca2+ elevation produced by BaP-7,8-diol-9,10-epoxide, suggesting that this may be the
active metabolite responsible for Ca2+ elevation. The activation of PTKs is a significant
intermediary step involved in B cell receptor-mediated proliferation and activation.
Previous work in our laboratory has demonstrated that PAHs, such as DMBA, activate
Src-family protein tyrosine kinases. The final goal of this project was to examine the role
of protein tyrosine kinase (PTK) activity in PAH-induced alterations in Ca2+ homeostasis.
Pretreatment o f cells with a potent PTK inhibitor, herbimycin A resulted in a significant
reduction o f the Ca2+ elevation produced by BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide,
suggesting that PTKs play a role in Ca2+ elevation. These two BaP metabolites also
produced an increase in tyrosine phosphorylation o f Syk and Lyn tyrosine kinases, which
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correlates with the activation of these PTKs. In summary, these results suggest that PAHs
mediate immunosuppression by disrupting intracellular Ca2+ homeostasis and these
alterations in Ca2* are possibly associated with cytochrome P450 and protein tyrosine
kinase activity.
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GENERAL INTRODUCTION

POLYCYCLIC AROM ATIC HYDROCARBONS
Polycyclic aromatic hydrocarbons (PAHs) are a diverse class of ubiquitous
environmental and occupational contaminants that have potentially important human
health implications. PAHs are formed primarily by the incomplete combustion of organic
materials and are found throughout the environment in air, water, and soil (U.S. DHHS,
1993). As lipophilic compounds, PAHs occur in anthracene-, phenanthracene-, or pyrenebased forms which can be methylated, nonmethylated, or nitro-substituted. Anthracene, is
a relatively biologically inert PAH, and is often considered to be one form of the
structural backbone of PAHs, which can vary by the addition and arrangement of
aromatic rings and/or aliphatic constituents (Dipple, 1994; Krieger etal., 1995). The
PAHs most extensively used in models of immunotoxicity and carcinogenicity are
benzo(a)pyrene (BaP) and 3-methylcholanthrene (3-MC), which are found
environmentally, and 7,12-dimethylbenz(a)anthracene (DMBA), a methylated, synthetic
PAH prototype (reviewed in Davila et al'., 1995). The structures of various PAHs, as well
as a halogenated aromatic hydrocarbon, 2,3,7,8-tetrachlorodibenzo(p)dioxin, are shown in
Figure 1. As a general rule, PAHs that are carcinogenic are immunotoxic, while
noncarcinogenic PAHs are typically not immunotoxic (Table 1) and this correlation
between PAH carcinogenicity and immunotoxicity is observed in vivo (Silkworth et al.,
1984; White & Holsapple, 1984; Ward et al., 1985). This information suggests that both
PAH-induced immunotoxicity and carcinogenicity involve common mechanism(s).
Evaluating PAHs that are structurally similar, but vary in levels of immunotoxicity, may

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 1. Structures of various polycyclic aromatic hydrocarbons (PAHs) and
halogenated aromatic hydrocarbons. 3-methylchoIanthrene (3-MC), anthracene (ANTH),
7,12-dimethylbenz(a)anthracene (DMBA), benz(a)anthracene (BA), benzo(a)pyrene
(BaP), benzo(e)pyrene (BeP), 2,3,7,8-tetrachlorodibenzo(p)dioxin (TCDD), and
dibenzo(a,h)anthracene (DAH).
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TABLE 1

ASSOCIATION BETWEEN PAH/HAH IMMUNOTOXICITY AND
CARCINOGENICITY

PAH

IMMUNOTOXICITY

CARCINOGENICITY

7,12-Dimethylbenz(a)anthracene
(DMBA)

HIGH

HIGH

Benzo(a)pyrene (BaP)

HIGH

HIGH

3-Methylcholanthrene
(3-MC)

HIGH

HIGH

2,3,7,8-tetrachJorodibenzo(p)dioxin (TCDD)

MODERATE/HIGH

HIGH

Dibenz(a,h)anthracene (DAH)

MODERATE

MODERATE

Dibenzo(a,c)anthracene (DAC)

MODERATE

LOW

Anthacene (ANTH)

LOW

LOW

Benzo(e)pyrene

LOW

LOW
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provide insight in identifying specific structural moieties responsible for the toxicity o f a
particular compound or class of compounds.
Sources o f PAHs
PAHs enter the environment by various natural sources (Figure 2) including volcanic
eruptions, forest fires and the decay of organic materials. The principal sources
contributed by humans include the combustion o f fossil fuels for power generation
(particularly coal and diesel fuel), cigarette smoke, heat, transportation, and agricultural
and residential burning of wood (reviewed by White et al., 1994; Davila et al., 1997).
Residential wood burning and forest fires are the primary sources of PAHs released into
the environment. The human contributions of PAHs to the environment exceed the
volume released by natural sources (U.S. DHHS, 1993). These compounds gain entry
into the environment generally through emissions into the atmosphere, where they
integrate with particulate matter which deposits in surface waters and then can be
distributed throughout the environment. PAHs primarily concentrate in sediments and soil
due to their low solubility in water and strong adsorption to particulate matter. Additional
routes by which PAHs enter the environment include discharges from industrial outflows,
municipal waste water, and used motor oil (Davila et al., 1997). The widespread
distribution of PAHs poses the extreme difficulty of complete elimination of these
compounds from the environment.
Routes o f PAH Exposure
Animal and human exposure to PAHs is largely through a mixture of compounds
rather than to a single PAH, and these compounds can be absorbed following inhalation,
oral, or dermal exposure. For the United States human population, significant factors of

4
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Figure 2. Various contributions of polycyclic aromatic hydrocarbons (PAHs) into the
environment. PAHs enter the environment by natural sources including volcanic eruptions
and forest fires. Human contributions would include automobile exhaust and residential
wood burning. Routes of exposure would include the inhalation of cigarette and wood
smoke, skin contact with soot and tars, and the ingestion of contaminated grains and
charcoal-broiled meats. From: Davila et al., (1997). Toxicol. Ecotoxicol. News 4,5-9.
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exposure include the inhalation of cigarette and wood smoke, and air pollutants, skin
contact with soot and tars, and the ingestion of charcoal-broiled foods and contaminated
water (Zedeck, 1980). PAH exposure is estimated to be higher in particular members of
the population, such as individuals whose occupation involves coke and gas production,
working with tar, coal, mining or chimney sweeping, smokers, and people living with
smokers, and persons living in a highly industrialized, polluted cities or near hazardous
waste sites.
Surprisingly, the major source of exposure to PAHs is through ingestion (U.S. DHHS,
1993). The main factors contributing to the presence o f PAHs in the food supply are the
growth of plants in contaminated soils, which can absorb PAHs through their roots, and
the atmospheric deposition of PAH on plant leaves. Additionally, the preparation of
certain foods can also augment exposure to PAHs. Smoked or charcoal-broiled meats, for
example, contain larger amounts o f PAHs than oven-cooked or boiled foods. A charcoalbroiled steak may contain between 6 and 50 pg of BaP/kg, and for the average 200 g (8
oz) steak, ranges from 1.2 - 10 pg (Lijinsky, 1991). The quantity of carcinogenic PAHs in
the average American diet has been estimated to be 1-5 pg/day, with charcoal-broiled or
smoked meats or contaminated grains being the major contributing sources (U.S. DHHS,
1993).
PAHs have been detected in surface waters, and PAHs concentrating in the sediment
can bioaccumulate in bottom-dwelling aquatic organisms, including fish, shrimp, and
clams. The ability of certain aquatic organisms to metabolize and eliminate PAHs,
however, usually inhibits the biomagnification of PAHs in the food chain. In U.S.
groundwaters, it has been estimated that the average total daily intake o f PAHs from

6
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drinking water for an individual in the general population is 0.027 pg. For the non
smoking individual, the inhalation of ambient air is a major secondary source o f PAH
exposure, which contributes an average of 0.16 pg/day. A person who smokes one pack
of unfiltered cigarettes per day, however, inhales an additional 2-5 pg o f PAHs (U.S.
DHHS, 1993).
BMMUNOTOXICITY OF PAHs
Several PAHs have been found to be potent immunosuppressants, and for this reason,
these environmental contaminants have been studied with regard to their persistent
disruption o f normal immune function. Numerous investigators have demonstrated the
immunosuppressive effects of PAHs on both humoral and cell-mediated immune responses
(Table 2), primarily using rodent tissue exposed both in vivo and in vitro (White et al.,
1994; Davila et al., 1995). In general, PAHs at high doses are cytotoxic, resulting in
lymphoid organ atrophy, while low-dose PAH exposure may induce immunosuppression
without evident cytotoxicity.
Cell-Mediated Immunity
T lymphocytes, natural killer (NK) cells, and macrophages are responsible for and
involved in cell-mediated immune responses. Cell-mediated immunity is primarily
responsible for the elimination of cancerous cells, foreign graft tissue, cellular pathogens,
and virus-infected cells. PAHs produce a multitude of toxic effects on the cell-mediated
immune system and the immunosuppressive effects of PAHs have been extensively
characterized in functional tests of cell-mediated immunity by several investigators. In
vitro exposure of murine spleen cells to immunotoxic PAHs such as DMBA (the
prototype methylated PAH), results in the suppression of several cell-mediated immune

7
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TABLE 2
IMMUNOTOXIC EFFECTS OF PAHs ON DIFFERENT SYSTEMS

IMMUNOTOXICITY

REFERENCE

Suppression of B cells to T-dependent antigens

Dean etal, 1983, 1985
Burchiel, 1988
Kawabata & White, 1987
White et al, 1985
Thurmond et al, 1988

Suppression of B cells to T-independent
antigens

Ward etal, 1986
Wood & Holsapple, 1993
Burchiel et al, 1990
Ladies et al, 1992b

Apoptosis

Hardin e ta l, 1992
Burchiel et al, 1992, 1993

Decreased proliferation to T cell mitogens

Decreased cell-mediated responses

Lymphoid cell death

Dean etal, 1983, 1985, 1986
Burchiel et al, 1990
Pallardy et al, 1988, 1992
Krieger et al, 1995
Davila etal, 1996
Mudzinski, 1993
Wojandi et al, 1984
Wojandi & Alfred, 1984
House & Dean, 1987
Comaco ffe ta l, 1988
Burchiel et al, 1988, 1990, 1992
Davis etal, 1991
White etal, 1985
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responses, including the production of interleukin 2 (IL-2), proliferation in response to
the T-cell mitogens, phytohemagglutinin (PHA) and concanavalin A (Con A), and the
production of cytotoxic T lymphocytes (CTL) (House et al., 1987a, 1989; Pallardy etal.,
1988; Thurmond et al., 1988; Burchiel etal., 1990).
In vivo studies have shown that DMBA suppresses delayed-type hypersensitivity
responses and increases host susceptibility to bacterial and tumor challenge (Dean et al.,
1985, 1986; Ward etal., 1984, 1985), as well as depresses NK cell activity, CTL activity,
and T cell proliferation to mitogens (House et al., 1987; Pallardy et al., 1988; Thurmond
etal., 1988). Persistent suppression of cell-mediated immune responses is also observed
with BaP exposure. In vivo, BaP decreases CTL activity while in vitro exposure to BaP
leads to the suppression o f mixed lymphocyte responses (MLR) (Wojdani et al., 1984;
House & Dean, 1987; Thurmond et al., 1988). The non-immunotoxic PAH, BeP,
however, only moderately inhibits CTL activity and has no outstanding effects on the cellmediated aspects of immune function (Wojandi & Alfred, 1984). Although the majority of
studies conducted examining the effects of PAHs on the immune system have been
performed in the murine model, there is limited information characterizing the effects of
PAHs on human immune function. In vitro incubations o f human lymphocytes with BaP
and DMBA result in the suppression of mitogen-stimulated T-cell proliferation responses
(Pallardy etal., 1992; Mudzinski, 1993; Krieger etal., 1995). In addition, our
laboratory has recently demonstrated that immunotoxic and carcinogenic PAHs such as
BaP, DMBA, 3-MC, and certain BaP metabolites, inhibit mitogen-induced human
peripheral blood T lymphocyte proliferation (Davila et al., 1996).
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Humoral Immunity
The effects of PAHs on humoral immunity have been studied extensively because
humoral immune function is the most sensitive indicator of the immunotoxicity produced
by PAHs (Blanton etal., 1986; Ward et al., 1986; Luster et al., 1992; Davila etal.,
1995). Several investigators have demonstrated in vivo and in vitro that DMBA
suppresses both the IgG and IgM B cell response to T-dependent antigens as well as the
IgM response to T-independent antigens (Ward et al., 1984; Dean e ta l, 1985; White et
al., 1985; Burchiel etal., 1988; Ladies etal., 1991). Additionally, the IgM and IgG
antibody response to the T-dependent antigen, sheep red blood cell (SRBC), is persistently
inhibited (4-8 weeks) by DMBA exposure (Ward et al., 1986). In vitro measures of Tdependent B cell antibody responses to antigen stimulation is also suppressed after both
in vivo and in vitro exposures to BaP and DMBA (White et al., 1985; Ladies et al., 1991,
1992b). Studies involving T-independent (lipopolysaccharide- or pokeweed mitogenstimulated) B cell responses have demonstrated that both in vivo and in vitro treatments
with DMBA produce a decrease in T-independent polyclonal B cell antibody production
(Dean et al., 1986; Ward et al., 1986). Additionally, in vivo exposure to BaP results in
suppression o f antibody responses to particular T-independent antigens in mature, but not
immature, murine splenic B cells (Ladies etal., 1992a, 1992b).
It has been documented that other highly carcinogenic PAHs, including BaP and 3methylcholanthrene (3-MC), and moderately carcinogenic PAHs, including
dibenz(a,c)anthracene (DAC) and dibenz(a,h)anthracene (DAH), also decrease antibody
production to SRBC after in vivo subchronic exposures (Malmgren et al., 1952; Lubet et
al., 1984; W hites/al., 1985). Alternatively, noncarcinogenicPAHs, including
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anthracene and benzo(e)pyrene (BeP), do not produce a suppression in antibody responses
(Stjemsward etal., 1965, 1966; Dean etal., 1983; White e ta l., 1985).
Wood and Holsapple (1993) demonstrated that DMBA produced a suppression of
superantigen toxic shock syndrome toxin-induced B cell proliferation and antibody
secretion. Our lab has shown that anti-IgD-stimulated proliferation of murine B
lymphocytes following in vivo exposure to DMBA is significantly suppressed, as measured
by [3H]thymidine incorporation (Davis & Burchiel, 1992). In addition, in vivo subchronic
exposure of DMBA resulted in a reduction of the number o f mature B cells and T cells in
the spleens of treated B6C3F1 mice (Burchiel et al., 1988).
Although numerous studies have demonstrated the immunotoxic effects of PAHs on
both humoral and cell-mediated immune responses, the cellular and molecular
mechanism(s) responsible for PAH-induced immunosuppression have not been fully
characterized, and there is high probability that a combination o f intracellular signaling
mechanisms are involved.
MECHANSIMS OF PAH ACTION
While the molecular mechanism(s) by which PAHs exert their immunotoxic effect,
have not been definitively characterized in either animal or human systems, it is very likely
that several mechanisms play an important role in PAH-induced immunosuppression.
Metabolism and PAH Carcinogenicity
Polycyclic aromatic hydrocarbons induce cancer in rodents in the absence o f known
additional environmental or chemical signals and, therefore, are considered to be complete
carcinogens capable of tumor initiation, promotion, and progression (Conney et al., 1994;
Dipple, 1994). The carcinogenic and mutagenic actions of PAHs are mediated by the
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formation of reactive metabolites via cytochrome P450 metabolism rather than the parent
compound. These metabolites are reactive electrophiles which are not only capable of
binding cellular nucleophilic sites such as deoxyribonucleic acid (DNA), but proteins that
play a pivotal role in signaling pathways involved in cellular function. These metabolites
can be reactive and, therefore, attack sulfhydryl sensitive proteins involved in Ca2+dependent signal transduction pathways. It has been suggested by several investigators,
that the immunosuppressive effects of PAHs, such as DMBA and BaP, are also mediated
by their reactive metabolites (Kawabata & White, 1989; Ladies etal., 1991). Studies
evaluating the correlation between metabolism and immunosuppression have shown that
PAHs known to be carcinogenic, required metabolic activation to carcinogenic and
mutagenic metabolites, while noncarcinogenic PAHs did not undergo metabolic
transformation (White et al., 1985; White, 1986). Cytochrome P450 1A1, 1A2, and
IB 1are major P450 isozymes involved in PAH metabolism, and each is induced by
exposure to PAHs, such as BaP and dioxins including 2,3,7,8-tetrachlorodibenzo(p)dioxin
(Whitlock, 1987; Sterling etal., 1994; Shimada et al., 1996).
Calcium Homeostasis
Cytosolic Ca2* is an important intracellular second-messenger, and alterations in the
concentration of Ca2+ can affect various physiological processes (Berridge, 1993). It has
been well established that the mobilization of intracellular Ca2+ plays a prominent role in T
and B cell receptor-mediated signaling pathways involved in cell activation (Cambier &
Ransom, 1987; Weiss & Littman, 1994). Studies using Ca2+-indicators have shown that
the concentration of cytosolic Ca2+ in unstimulated cells is maintained around 100 nM,
which is approximately 10s times lower than extracellular Ca2+ levels (Carafoli, 1989;
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Tymianski, 1996). This significant difference between extracellular and intracellular Ca2*
levels produces an inwardly directed movement of Ca2* into the cell, which is balanced by
extrusion of Ca2+ through the plasma membrane and Ca2*-sequestering systems distributed
in mitochondrial, nuclear, and endoplasmic reticular membranes (Orrenius etal., 1996).
Although mitochondria and the nucleus can accumulate large amounts of Ca2r, it is the
endoplasmic reticulum that is the major intracellular Ca2+ store. Generally, increases in
cytosolic Ca2+ is initiated by the transient release of Ca2+ from storage organelles such as
the endoplasmic reticulum, followed by a sustained influx of extracellular Ca2+ (Premack
& Gardner, 1992). This elevation in intracellular Ca2* is a fundamental component of the
signaling pathway, driving the resting levels of cytosolic Ca2+ up to concentrations as high
as several pM, which are required for the activation o f critical Ca2+-dependent proteins
involved in cellular function. The regulatory effects o f Ca2+ are most often mediated by
these Ca2+-binding/dependent proteins by way o f altering the phosphorylation status of
target proteins (Premack & Gardner, 1994).
In establishing that Ca2+ is a key intracellular regulator o f numerous cellular processes,
there has come a greater understanding that Ca2+ can be an important mediator of
pathological and toxicological processes. This thought has led to the generation of the
calcium hypothesis o f cell injury which proposes that disturbance of cytoplasmic Ca2* may
be directly involved in the development of cytotoxic cell death (Metcalfe et al., 1980;
Orrenius et al., 1996). Researchers have shown that disruptions in Ca-2+ homeostasis is
often associated with cell injury and may be a central component in the development of
cytotoxicity (Schanne et al., 1979; Tymianski, 1996). Various environmental xenobiotics,
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such as PAHs, can interfere with Ca2+ homeostasis and Ca2+-dependent signaling pathways
resulting in a loss of normal cellular activation and function.
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RESEARCH OBJECTIVES
The objective of these studies was to examine the hypothesis that polycyclic aromatic
hydrocarbons exert their immunomodulatory effects on human B lymphocytes by
interfering with Ca2+ homeostasis which ultimately leads to the disruption of Ca2+dependent signaling pathways and biochemical events responsible for cellular activation
and functioning.
Several studies conducted in our laboratory have demonstrated in both T and B
lymphocytes that PAH-induced immunosuppression involves disrupting intracellular Ca2*
homeostasis and signaling pathways. We have observed that in vivo and in vitro exposure
to DMBA results in an elevation of baseline Ca2+ in resting cells, and inhibits Ca2+
mobilization after PHA stimulation in the Jurkat human T cell line and murine T cells
(Burchiel et al., 1990; Burchiel etal., 1991). IntheHPB-ALL human T cell line, both
highly immunosuppressive PAHs, including DMBA and BaP, and moderately
immunosuppressive PAHs, including dibenz(a,h)anthracene (DAH) and 9,10dimethylanthracene (DMA), produced a sustained (at least 4 hours) rise in intracellular
Ca2+, while PAHs that are minimally immunosuppressive, including DAC, BeP,
anthracene, and benz(a)anthracene (BA), produced only a small and transient (3 minutes)
elevation in Ca2+(Krieger et al., 1994). It appears that the methylation of anthracene at
the 9,10-(DMA) or the 7,12-(DMBA) positions increased the duration of the Ca2+
elevation suggesting that PAHs may affect different constituents of signal transduction
pathways in a structure-dependent manner (Davila etal., 1995). A PAH-induced
disruption in Ca2+ mobilization also occurs in nylon wool purified T lymphocytes (~85%
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pure) isolated from human peripheral blood following Ficoll-Hypaque density gradient
centrifugation (Mounho et al., unpublished data).
In the B lymphocyte system, both in vivo and in vitro treatment with DMBA produced
alterations in baseline Ca2+levels (Burchiel etal., 1990, 1992; Davis & Burchiel, 1992).
Collectively, these findings suggest that the immunomodulatory effects of PAHs involves
alterations in intracellular Ca2+ ultimately leading to a disruption of Ca2‘-dependent
signaling pathways, and that B cells may be an important cellular target.
A second objective of these studies was to examine the role of cytochrome P450
metabolism and P450-derived BaP metabolites in PAH-induced alterations in free
intracellular Ca2+ in human peripheral B cells and in the Daudi human B cell line. While
studies have shown that PAHs, such as DMBA and BaP maybe directly
immunosuppressive (Ladies etal., 1991), others have demonstrated the PAH-induced
immunotoxicity and carcinogenicity is mediated by the formation of reactive metabolites
(Thakker et al., 1977; Ladies e ta l, 1991; Mudzinski, 1993). The biotransformation of
BaP, for example, is necessary for its conversion to reactive electrophiles capable of
binding DNA and tumor initiation (Bauer etal., 1995). The most important metabolites
involved in the metabolic oxidations of BaP by cytochrome P450 are known as the bayregion dihydrodiol-epoxides (Thakker et al., 1985; Dipple et al., 1994). It has been
shown that the major human cytochrome P450 proteins involved in the metabolism of BaP
are 1A1 and 1A2, 1B1, and 3A4 (McManus et al., 1990; Bauer etal., 1995; Shimadaef
al, 1996).
Murine spleen cells are more sensitive to the reactive metabolites of BaP than the
parent compound and lymphoid tissues are capable o f generating these metabolites for the
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parent compound (Kawabata & White, 1989; Ladies et al., 1991). Recent studies in our
laboratory have demonstrated the reactive metabolites of DMBA and BaP play a role in
the immunosuppressive effects of DMBA and BaP in human peripheral blood
mononuclear cells (Davila etal., 1996; Romero et al., 1997). It has also been
demonstrated that cytochrome P450 metabolism is required for the immunotoxicity of BaP
and DMBA and that certain metabolites are potent inhibitors of murine immune responses
(Ladies etal., 1991, 1992b). It appears, therefore, that the immunotoxic and carcinogenic
potential o f PAHs may be associated with a common metabolic mechanism leading to the
formation o f reactive metabolites.
A third objective of these studies was to examine the association between PAHinduced alterations in Ca2+ homeostasis and protein tyrosine kinase activity in human B
cells. It has been well established that the activation of protein tyrosine kinases is a
significant intermediary step involved in membrane antigen receptor-mediated B cell
proliferation and function (Pure' & Tardelli, 1992; Yamanashi et al., 1992; Harwood &
Cambier, 1993). In light of these observations, work in our laboratory has been
conducted to determine the effects of PAHs on kinases responsible for stimulating
downstream signaling events involved in B and T cell function. It has been observed in
HPB-ALL human T cells that the rapid elevation in intracellular Ca2+ produced by DMBA
is accompanied by a transient increase in inositol 1,4,5-triphosphate (IP3) formation and
tyrosine phosphorylation of PLCy-1. Additionally, the activation of the T cell receptorassociated Src-family kinases, Fyn and Lck, is also modulated by DMBA. Collectively,
these findings suggest that Fyn and Lck kinases may be responsible for the
phosphorylation of PLCy-1 resulting in IP3 formation and mobilization of intracellular
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Ca2+, and these events may be altered by DMBA exposure (Archuleta et al, 1993).
Figure 3 represents both T and B cell receptor-mediated signaling pathways and
metabolism of xenobiotics which may be disrupted by PAHs, as well as HAHs, such as
TCDD. Genistein, a protein tyrosine kinase (PTK) inhibitor, partially inhibits both the
rapid and sustained elevation in Ca2+produced by PAHs, while staurosporine and
calphostin C, protein kinase C (PKC) inhibitors, have no effect (Krieger et al., 1995).
Based on these data, it appears that DMBA-induced tyrosine kinase activation also plays a
role in producing both an early and sustained rise in intracellular Ca2+ in the HPB-ALL cell
line. In the murine B-lymphoma A20.1 cell line, both immunosuppressive and non
immunosuppressive PAHs produce an increase in tyrosine phosphorylation. This implies
that PAHs may modulate intracellular signaling pathways in B lymphocytes by enhancing
kinase activity (Davila et al., 1995).
In summary, these studies have provided initial insights into the putative mechanisms
involved in PAH-induced immunomodulatory effects in B lymphocytes. Collectively,
these data suggest that PAHs may exert their immunomodulatory effects in B lymphocytes
by producing a disruption of kinase activity leading to an elevation in intracellular Ca2+,
which eventually alters signaling pathways involved in cell growth and activation.
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Figure 3. Schematic of both T cell and B cell antigen receptor mediated signaling
pathways which may be susceptible to the effects of PAHs. While there may be several
similarities between T and B cell receptor mediated signaling, there may also be some
significant differences.
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CENTRAL HYPOTHESES

•

Polycyclic aromatic hydrocarbons (PAHs) exert immunotoxic effects in human B
lymphocytes by interfering with calcium (Ca2+) homeostasis, ultimately leading to a
disruption in Ca2+-dependent signal transduction mechanisms involved in B cell
activation and proliferation.

•

PAH-induced alterations in Ca2+ homeostasis may be associated with cytochrome
P450 metabolism and increased protein tyrosine phosphorylation.
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SPECIFIC AIMS

1. Determine the differential sensitivity of human peripheral blood mononuclear
cells (HPBMCs), including light scatter-gated and/or surface marker defined
monocytes, B cells, and T cells, to intracellular Ca2+ changes produced by PAHs
using multiparameter flow cytometric analysis.

a. Determine the dose- and time-dependence for PAH-induced Ca2+ elevation in
HPBMCs (T cells, B cells, and monocytes) using the Ca2+-chelating dyes, Fluo-3
and Fura Red in conjunction with phycoerythrin (PE)-conjugated murine
monoclonal antibodies to human CD 19 (B cells), CD3 (T cells), and CD 14
(monocytes).
b. Determine structure activity relationships for various PAHs (DMBA, BaP, BeP,
ANTH) and the halogenated aromatic hydrocarbon (HAH), 2,3,7,8tetrachlorodibenzo(p)dioxin (TCDD) for Ca2+ elevation in HPBMCs.

2. Develop in vitro models of human B cell activation that can be utilized to
examine the mechanisms of PAH-induced Ca2+ mobilization.

a.

Perform selective structure-activity and kinetic studies of PAH-induced (BaP and
BaP metabolites) Ca2+ elevation in NCL-BL2126, Daudi, Ramos, and Raji human
B cell lines, and characterize which cell line is best for the studies.
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b. Characterize and establish a human B cell line to serve as an in vitro model for
human B cell protein tyrosine kinase phosphorylation and metabolism studies.

3. Evaluate the effects of cytochrome P450-mediated BaP metabolites and the
potential role of P450 metabolism in PAH-induced alterations in free intracellular
Ca2+ mobilization in human B lymphocytes.

a.

Determine the dose- and time-dependence of BaP-induced Ca2+ elevations in light
scatter gated human peripheral lymphocytes and monocytes and examine the
effect of a-naphthofiavone (ANF), an inhibitor o f cytochrome P450 activity, on
altered Ca2+ mobilization produced by BaP.

b.

Establish a dose- and time-dependent response o f BaP and two BaP metabolites,
benzo(a)pyrene-trans-7,8-dihydrodiol (+) (BaP-7,8-diol), and benzo(a)pyrene-r7,t-8-dihydrodiol-t-9,10-epoxide (±), (anti) (BaP-7,8-diol-9,10-epoxide), and
BeP on intracellular Ca2+ in the Daudi human B cell line.

c. Compare the direct effect of BaP and two BaP metabolites, BaP-7,8-diol and
BaP-7,8-diol-9,10- epoxide, and BeP on intracellular Ca2+ in Daudi cells.
d. Evaluate the effects of ANF on intracellular Ca2+ alterations produced by Bap7.8-diol and BaP-7,8-dioI-9,10-epoxide in Daudi cells.
e. Establish a dose-response relationship and compare the direct effect of BaP, Bap7.8-diol and BaP-7,8-diol-9,10-epoxide, and BeP on intracellular Ca2+ in CD 19+
human peripheral B lymphocytes.
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4. Evaluate the association between disruptions in intracellular Ca2+ homeostasis
produced by BaP metabolites (BaP-7,8-diol and BaP-7,8-dioI-9,10-epoxide) and
protein tyrosine kinase activity.

a. Establish a dose and pretreatment response of herbimycin A, a specific protein
tyrosine kinase inhibitor, in Daudi cells.
b. Evaluate the role of protein tyrosine kinase activity in PAH-induced Ca2+
mobilization by examining the effects of protein tyrosine kinase inhibition by
herbimycin A on altered Ca2+ mobilization produced by BaP-7,8-diol and Bap7,8-diol epoxide using multiparameter flow cytometric analysis.
c. Establish a dose- and time-dependent response in increased protein tyrosine
phosphorylation produced by BaP-7,8-diol and BaP-7,8-diol epoxide using
immunoblot analysis.
d. Establish a dose- and time-dependent response and evaluate increased protein
tyrosine kinase activity of Syk and Lyn protein kinases by examining increased
autophosphorylation using immunoprecipitated phosphotyrosine proteins and
immunoblot analysis.
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CHAPTER I

Characterization of Intracellular Calcium Responses Produced by Polycydic
Aromatic Hydrocarbons in Surface-Marker Defined Human Peripheral Blood
Mononuclear Cells

BACKGROUND AND SIGNIFICANCE

The humoral and cell-mediated immune systems are common targets for the toxic
effects of polycyclic aromatic hydrocarbons (PAHs) (White et al., 1994; Davila et al.,
1995). Studies have shown that 7,12-dimethylbenz(a)anthracene (DMBA) and
benzo(a)pyrene (BaP) suppress T-dependent B cell responses after in vivo or in vitro
antigen stimulation (Ward et al., 1984; White etal., 1985; Burchiel etal., 1988; Ladies
et al., 1991, 1992b). T-independent B cell responses have also been shown to be
suppressed by in vivo or in vitro treatments with DMBA or BaP resulting in a decrease in
antibody production (Ward e t a l , 1984; Ladies et al., 1992). Several T cell-dependent
immune responses have also been shown to be sensitive to PAH-induced
immunosuppression (Ward et al., 1986; House etal., 1987; Pallardy et al., 1988, 1992).
Our laboratory has shown that both murine T and B cell proliferation is inhibited by
DMBA and the effect of the PAH is quite persistent, producing immunosuppression for
eight or more weeks (Burchiel et al., 1990). Suppression of murine immune responses
occurs at doses of DMBA that are not cytotoxic to lymphocytes, demonstrating that this
long-lived effect may resemble the induction of tolerance. It has been shown that DMBA
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increases intracellular Ca2+in murine and human B and T lymphocytes, and our laboratory
has hypothesized that the elevation of intracellular Ca2* occurs by way of activation of
protein tyrosine kinases (Archuleta et al., 1993) or inhibition of sarcoplasmic/endoplasmic
reticulum calcium ATPase (SERCA) activity (Krieger et al., 1995).
As an intracellular second-messenger, calcium is an important component of the
immune response and alterations in intracellular Ca2+ affect both humoral (B cell) and cellmediated (T cell) immunity (Aldo-Benson & Tsao, 1987). The mobilization of
intracellular Ca2+ plays an essential role in signaling pathways involved in lymphocyte
activation and gives the T cell or B cell receptor (TCR, BCR) the ability to transduce
intracellular signals to the nucleus (Choquett et al., 1994). Elevation of intracellular Ca2"
leads to a disruption in antigen and mitogen receptor signaling and may cause tolerance in
lymphocytes and it is well known that excess Ca2+ signaling in lymphocytes in the absence
of co-stimulatory signals leads to the induction o f tolerance (Aldo-Benson & Tsao, 1987).
Past studies have shown that certain PAHs produce an elevation of free intracellular
Ca2* in the Jurkat and HPB-ALL human T cell lines, as well as nylon wool T lymphocytes
isolated from human peripheral blood (Burchiel et al., 1990; Krieger, et al., 1994;
Mounho et al., unpublished data). In addition, a disruption of baseline Ca2+ has also been
observed in resting murine splenic B cells and the murine B cell lymphoma A20.1 cell line
exposed to DMBA (Davis & Burchiel, 1992; Burchiel et al., 1993). In structure-activity
studies, our laboratory has demonstrated in human T cells that there is a strong
relationship between the immunotoxicity of PAHs and their ability to maintain elevated
levels of intracellular Ca2+(Krieger etal., 1994).
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The mechanism(s) by which PAHs exert their immunotoxic effects have not been well
characterized in normal human peripheral lymphocytes and monocytes. For this reason,
we and others have attempted to define the underlying cellular mechanisms of PAHinduced immunotoxicity of various human T and B cell lines, as well as in normal human
peripheral blood mononuclear cells (HPBMC) (Comacoff et al., 1988).
Our data suggests that PAHs exert their immunomodulatory effects by interfering with
Ca2+-dependent intracellular signal transduction pathways involved in cell proliferation and
activation. Since we have not previously characterized the effects o f various PAHs or the
halogenated aromatic hydrocarbon (HAH), 2,3,7,8-tetrachlorodibenzo(p)dioxin (TCDD)
on Ca2+ signaling pathways in normal human immune cells, the purpose of these studies
was to determine whether PAHs increase intracellular Ca2+ in HPBMC and to determine
the differential sensitivity of various subsets of cells to the Ca2+ elevation using
multiparameter flow cytometry. In preliminary studies, we determined the optimal doses
and timing for examining the effects of PAHs on HPBMC Ca2+elevation. We also noted
significant variability in the responses of donor HPBMCs. Therefore, in the present
studies, we report the results of ten consecutive normal donors analyzed under identical
conditions, in an attempt to control for as many parameters as possible to limit variability.
We examined the effects of two immunosuppressive PAHs (BaP and DMBA), two non
immunosuppressive PAHs, benzo(e)pyrene (BeP) and anthracene (ANTH), and TCDD on
intracellular Ca2+ levels in surface marker-defined human peripheral blood mononuclear
cells at 20, 42, and 66 hour time points. In the past, our laboratory has focused on the
effects of PAHs on intracellular Ca2+ at shorter time points, and in these studies, we have
focused on longer exposure periods.
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MATERIALS AND METHODS

Reagents. All polycyclic aromatic hydrocarbons (PAHs; * 95% purity as assessed by
the manufacturer), including 7,12-dimethylbenz(a)anthracene, benzo(a)pyrene,
benzo(e)pyrene, and anthracene were purchased from Sigma Chemical Co. (St. Louis,
MO). 2,3, 7 , 8-tetrachlorodibenzo(p)dioxin (TCDD; 99% purity) was purchased from
Cambridge Isotopes Labs (Andover, MA). PAHs and TCDD were dissolved in tissue
culture grade (> 99% purity) anhydrous dimethylsulfoxide (DMSO; Sigma, St. Louis,
MO), which also served as the vehicle control. PAHs were prepared immediately prior to
use, shielded from light, and visually inspected to affirm that the compounds were
dissolved in DMSO. The final concentration of DMSO in all cell cultures was < 0.1%.
Control cultures without DMSO did not differ from cultures containing DMSO, and it was
concluded that DMSO at the concentrations used did not produce any measurable effect
on intracellular Ca2+ responses.
Preparation o f H um an Peripheral Blood Mononuclear Cells (HPBMC). Human
peripheral blood was obtained from the Clinical Research Center (CRC) at the University
of New Mexico Hospital in Albuquerque, NM. Volunteer donors were clinically normal
adults in the normal range for peripheral blood differential cell counts (Complete Blood
Cell, CBC analysis), and pre-screened to exclude individuals taking prescribed or over the
counter medications, having chronic or acute illness, and had not donated a unit of blood
for at least 8 weeks. The CRC volunteer donors were between the ages of 23 and 44,
who were all non-smokers except one donor. Venous blood was collected into sterile,
heparinized bags and centrifuged 2 times for 5 minutes each (1200 x g; 24 °C) to enrich
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for leukocytes. The leukocyte layer was diluted with equal parts of sterile phosphate
buffered saline (PBS), and layered over a ficoll density gradient solution (Fico/LiteLymphoH, Atlanta Biological, Norcross, GA). After centrifugation (500 x g; 24 °C; 30
min), the cell layer at the ficoll-plasma interface (mononuclear cell layer) was collected,
washed 3 times in PBS to remove any excess ficoll, and resuspended in RPMI 1640
medium (BioWhittaker, Walkersville, MD) containing 10% fetal bovine serum (FBS;
Hyclone, Logan, UT) and 1% penicillin/streptomycin (pen/strep; Bio Whittaker,
Walkersville, MD). The total time from collection of blood to culturing o f HPBMC was
typically three hours. The percentage of monocytes in the HPMC ficoll preparation was
typically around 19% (Davila et al., 1996).
Flow Cytometry Measurement o f Calcium. For the comparison o f the effects of
PAHs on intracellular Ca2+ in human peripheral T cells, B cells, and monocytes, ficoll
density isolated mononuclear cells resuspended in complete media were treated with PAHs
and plated at a concentration of 1 x 106 cells/ml into 24-well or 12-well plates in a volume
o f 1-3 mis. Quadruplicate samples were prepared for each control and treatment group,
and alterations in free intracellular Ca2+ levels were measured using a Coulter ELITE flow
cytometer (Hialeah, FL) and the Ca2+-chelating dyes, Fluo-3 AM and Fura-Red AM
(Molecular Probes, Eugene, OR), as a ratiometric indicator of Ca2+. The acetoxymethyl
(AM) ester form of Fluo-3 and Fura Red was used because once the lipophilic AM esters
enter the cell, they are hydrolyzed to the active free dye in the cytoplasm by intracellular
esterases (Haugland, 1993). Both o f these indicator dyes excite at 488 nm, and Fluo-3
fluoresces with increasing intensity in the green region when bound to Ca2+ and Fura-Red
fluoresces most intensely in the red region when it is not bound to Ca2+(see Figure 4).
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Figure 4. Fluorescence emission spectra of Fluo-3 and Fura Red Ca2+ indicators
simultaneously excited at 488 nm in solutions containing zero to 39.8 gM free Ca2\
Adapted from: Haugland, R.P. (1996). Handbook o f Fluorescent Probes and Research
Chemicals, 6th Edition, 507-521.
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When used simultaneously, Fluo-3 and Fura Red exhibit reciprocal shifts in fluorescence
intensity upon binding Ca2+, and a low noise, highly sensitive Fluo-3 to Fura-Red
ratiometric measurement o f free intracellular Ca2+ is obtained (Novak & Rabinovitch,
1994). Unlike with other Ca2+-chelating fluorescence dyes, such as Indo-1, we have found
that the presence of PAHs did not interfere with the Fluo-3/Fura-Red fluorescence signal.
Samples were pelleted and resuspended in complete media containing 6 pM Fluo-3 and 13
pM Fura-Red in a volume of 100 pi and incubated at 37 °C for 1 hour, with cells being
resuspended * every 20 minutes to ensure even loading. Samples were then incubated for
an additional 30 min with phycoerythrin (PE)-conjugated murine monoclonal antibodies at
1 pg/1 x 106 cells (Caltag Laboratories, Burlingame, CA) to either CD3 (T cells), CD 14
(monocytes), or CD 19 (B cells) cell surface antigens. PE fluoresces in the orange region
and like Fluo-3 and Fura Red, excites at 488 nm. Matching isotype controls (IgG-2a for T
cells and monocytes, IgG-1 for B cells) was also used to account for non-specific binding
and to assist in gating on the specific cell populations. Results are shown as the change in
the Mean Channel Fluo-3/Fura-Red Fluorescence Ratio (MCFR) which is obtained by
subtracting the MCFR o f DMSO vehicle controls from the MCFR of PAH-treated
samples. The MCFR for control DMSO samples was typically electronically set at
channel 250 - 350, and the increase in channel number following PAH treatment is an
indication in the change of this ratio. Trypan blue (Sigma) was used to check cell viability
in all experiments which ranged from 92% - 99%. To ensure cells, chelators, and flow
cytometry detection systems were functioning correctly, 1 pM thapsigargin (Sigma),
which is a potent inhibitor o f the sarcoplasmic/endoplasmic reticulum calcium ATPase
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(SERCA) and induces Ca2+ mobilization without the generation o f IP3 (Premack &
Gardner, 1992), was used in all experiments as a positive control for Ca2* mobilization.
Statistical Design and Analysis. Data were analyzed for statistical differences
between DMSO control and treated groups using SigmaStat statistical software (Jandel
Scientific, San Rafeal, CA). ANOVA followed by Dunnett’s /-tests were performed on
sample means, with use o f a Mann-Whitney test when equal variance test failed.
Statistical significance is defined as a p value of p < 0.05.
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RESULTS

Time-Dependence o f Co?* Elevation by PAHs in Surface Marker-Defined HPBMC.
The time-dependence for PAH-induced Ca2+ elevation in subsets of HPBMC was assessed
using HPBMC obtained from five separate donors. Results from a representative donor
are shown in Figure 5. BaP and DMBA, but not BeP and ANTH, were found to produce
a statistically significant increase in intracellular Ca2+ following 20, 42, and 66 hours of
exposure in CD3" T cells, CD 19" B cells, and at 42 hours in CD 14" monocytes. Results
are shown as the change in the mean channel fluorescence ratio (MCFR) which was
obtained by subtracting the MCFR of DMSO controls for each subset from the MCFR of
PAH-treated samples. At the 20 hour time point, 10 pM DMBA produced a significant (p
< 0.05) rise in intracellular Ca2+ in the T and B cells, but this rise was not significant in
monocytes. BaP at 10 pM produced an elevation in Ca2+ in all three cell populations. At
42 hours, both DMBA and BaP significantly (p < 0.05) increased intracellular Ca2" in all
three cell populations. Interestingly, the BaP response appeared to peak in T cells at 42
hours, but appeared to be higher at 66 hours in B cells and perhaps monocytes. TCDD
(0.1 pM), BeP, and ANTH (both at 10 pM) also produced a rise in Ca2+ in monocytes,
but due to the variability in the monocyte DMSO control samples for Ca2" measurements
in this experiment, the effects of these agents were not statistically significant. At 66
hours, DMBA caused a significant Ca2+ rise only in T and B cells, but not in monocytes.
At all three time points, TCDD (0.1 pM) and 10 pM BeP and ANTH did not produce a
significant rise in Ca2+ in any of the cell populations.
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Figure 5. Intracellular calcium elevation in human peripheral blood T cells (CD3~), B
cells (CD 19*) and monocytes (CD 14*) treated for 20, 42, and 66 hours. Mononuclear cell
cultures were treated with either DMBA, BaP, BeP, or ANTH at a 10 pM concentration
or 0.1 pM TCDD. Cells were incubated with Fluo-3 and Fura Red and phycoerythrinconjugated murine monoclonal anti-human antibodies to either CD3, CD 19, or CD 14.
Results are shown a the change in Mean Channel Fluorescence (Fluo-3/Fura Red) Ratio
(MCFR) which is obtained by subtracting the MCFR o f DMSO solvent controls from the
MCFR of PAH-treated samples analyzed in quadruplicate. Values are mean ± S.E.M. for
one representative donor. *Indicates significant (p < 0.05) increases in free intracellular
Ca2+DMSO solvent control. Actual MCFR for samples having a change in MCFR < 0 are
as follows: CD3+ T cells - 20 hrs : DMSO = 238 ± 6.5, TCDD = 228 ± 9.7, BeP = 226 ±
7.4, ANTH = 236 ±6.2; 42 hrs: DMSO = 328 ± 11.0, TCDD = 318 ± 6.0, BeP = 319 ±
11.0, ANTH = 301 ± 10.0; 66 hrs: DMSO = 265 ± 5.6, BeP = 233 ±5.4, ANTH = 244 ±
3.3; CD19+B cells - 20 hrs: DMSO = 210 ± 3.8, TCDD = 203 ± 3.0; 42 hrs: DMSO =
225 ± 2.0; 66 hrs: DMSO = 271 ± 8.0; CD14+ Monocytes - 20 hrs: DMSO = 338 ±
12, TCDD = 331 ± 9.7, BeP = 322 ± 8.3, ANTH = 328 ± 6.5; 42 hrs: DMSO = 237 ±
5.0; 66 hrs: DMSO = 317 ± 2.9, TCDD = 309 ± 13.1, BeP = 310 ± 10.0, ANTH = 307
+ 4.4.
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Ca2+Elevation by Im m unotoxic PAHs in HPBMC Obtained fro m Ten Normal
Donors. Because the broadest Ca2* responses following PAH exposure in all three cell
populations were observed following 42 hour exposures in several donors, this time point
was chosen for comparing the effects of various PAHs and TCDD in HPMC obtained
from several separate donors. In Figure 6 , the pooled results are shown for ten replicate
studies performed using HPBMC obtained from different donors. The statistical results
from the ten individual experiments are shown in Table 3. As in Figure 5, all PAHs were
examined at 10 pM concentrations following a 42 hour exposure period, whereas TCDD
studies were performed a 0 .1 pM. DMBA and BaP produced a significant (p < 0.05)
increase in free intracellular Ca2* compared to the DMSO control in all CD3* T cells,
CD 19* B cells, and CD 14* monocytes. Interestingly, while TCDD produced a statistically
significant increase in intracellular Ca2+ in B cells in only 2 of 10 donors, the results for
the pooled 10 donors demonstrated an overall statistically significant change in Ca2+
responses in B cells, but not T cells.
In analyzing the pooled data for the relatively non-immunotoxic PAHs, BeP and
ANTH were not found to produce a significant Ca2+ elevation in any o f the three HPBMC
populations. However, as shown in Table 3, these PAHs were found to occasionally
produce a statistically significant increase in T cells, B cells, and/or monocytes in HPBMC
obtained from individual donors, following a 42 hour exposure. It is unclear why
relatively non-immunotoxic PAHs occasionally increase Ca2+ in some donors. One
possible explanation is some individuals may be more sensitive to the effects of PAHs than
others. However, there was a clear difference in the number of responders for the
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Figure 6. Calcium elevation in human peripheral blood T cells (CD3"), B cells (CD 19"),
and monocytes (CD 14") from 10 different donors treated for 42 hours and analyzed in
quadruplicate. 10 pM DMBA, BaP, BeP, ANTH, and 0.1 pM TCDD , were added to
human peripheral blood mononuclear cell cultures. Alterations in Ca were analyzed
using flow cytometry and the Ca2+-indicator dyes Fluo-3 AM and Fura Red AM, and
changes in MCFR were determined as previously described in Fig. 5. Cell populations
were identified using murine monoclonal anti-human antibodies to CD3, CD 19, or CD 14.
Between 70-80% of the cells gated as lymphocytes on the flow cytometer were T cells and
approximately 15% were B cells, whereas approximately 60-75% of the cells gated in the
monocyte region were monocytes. Values are Mean + S.E.M. for 10 different donors.
*Indicates significant (p < 0.05) increase in intracellular Ca2" compared to DMSO control.
The actual MCFR of samples a change in MCFR < 0 are as follows: CD3 + T cells DMSO = 283 ± 12.3, BeP = 279 ± 12.6; CD19+ B cells - DMSO = 263 ± 11.5; CD14+
Monocytes - DMSO = 329 ± 14.8.
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TABLE 3: Summarized Results for Ten Donors in the Average Change in Mean
Channel Fluorescence Ratio (MCFR) for Surface Marker-Defined HPBMC Treated
for 42 Hrs with PAHs"
PAH Tested
T Cells
B Cells
Monocytes
10 pM DMBA

38.4+ 12.1

53.4+11.7

7 of 10*
lOpMBaP

59.1 + 16.0

9 of 10*

17.2 ± 14.9

32.5 ± 10.6

NR
10 pM BeP

10 pM ANTH

0 .0

o f 10 *

83.2 ± 11.6

of 10 *

8

0.1 pM TCDD

8

2

+ 12.6

of 10 *

3.97 ± 12.8

57.8 ± 17.1
6

o f 10 *

83.6+17.9
8

o f 10 *

20.8 ± 14.5
3 o f 10*
28.5 + 16.8
o f 10 *

NR

1 of 10 *

16.7+14.0

17.7 ± 13.4

14.6 ± 14.3

1 of 10 *

3 o f 10*

1

of 10 *

1

“Intracellular calcium elevation in HPBMC T cells, B cells, and monocytes from 10
different donors treated with PAHs for 42 hours. Human mononuclear cells were
incubated with DMSO solvent control or PAHs at the concentrations shown and
alterations in Ca2+ were determined using flow cytometry, as described in Fig. 1. Cell
populations were identified using phycoerythrin-conjugated antibodies to CD3 (T cells),
CD 19 (B cells), or CD 14 (monocytes). Values are mean + S.E.M. for the total number of
donor tested. *Indicates the number o f donors that showed a MCFR significantly (p <
0.05) higher than DMSO control. NR = No response (i.e., no donors showed a MCFR
significantly higher than DMSO control).
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immunotoxic PAHs compared to the non-immunotoxic PAHs, with the great majority of
donors responding to BaP and DMBA.
In order to determine if the same Ca2+ response could be reproduced in donors that
were re-analyzed after several months, we performed the same flow cytometric analysis of
Ca2+ mobilization in human peripheral B and T lymphocytes and monocytes in donors
who had been previously studied. Again, HPBMC were treated for 42 hours with PAHs
and TCDD, and the effects on intracellular Ca2+ were compared to DMSO controls
(Figure 7). Figure 7a is a graph of the first experiment, and Fig 7b represents the same
experiment performed approximately 6 months later. In both experiments, DMBA and
BaP produced a significant (p < 0.05) elevation in intracellular Ca2+ in the T and B cell
populations. The reproducibility of these results suggests that this donor may be
consistently sensitive to these two PAHs. Interestingly, TCDD produced a small, but
statistically significant Ca2+ response in the monocytes in the first experiment but not in the
second. Additionally, the magnitude of the change in MCFR in the DMBA and BaP
samples was considerably higher in the second experiment. We believe that these results
reflect the day to day individual changes that occur in the human population which can be
contributing factors to the variability and complexity often encountered in human studies.
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Figure 7. Reproducibility o f PAH-induced Ca2+ elevation obtained in the same donor
after a 6 month interval. This is a representative experiment of 3 separate experiments
performed in different individual donors. DMBA, BaP, BeP, and ANTH (all 10 pM) and
0.1

pM TCDD were added to HPBMC cultures for 42 hours and alterations in Ca2+ were

analyzed as described as previous described. Cell populations were identified using
phycoerythrin-conjugated antibodies as previously described. Figure 7a represents the
first experiment and 7b is the graph of the same experiment performed in the same donor
and manner approximately 6 months later. Values are Mean ± S.E.M. for a single donor.
♦Indicates significant (p < 0.05) increase in Ca2+ compared to DMSO control. Actual
MCFR of samples having a change in MCFR < 0 is as follows: Figure 7a - T cells:
DMSO = 367 ± 4.0, TCDD = 351 ± 14.5, BeP = 339 ± 9.5, ANTH = 362 ± 12.0; B
cells: DMSO = 348 ± 5.5, TCDD = 324 ± 3.4, BeP = 335 ± 7.8, ANTH = 333 ± 4.9;
Monocytes: DMSO = 321 + 8.5, DMBA = 314 + 5.1, BeP = 311+ 5.2, ANTH = 313 +
4.4. Figure 7b - T cells: DMSO = 327 ± 5.0; B cells: DMSO = 348 + 9.5, TCDD = 344
+ 6.9, ANTH = 340 ± 4.6; Monocytes: DMSO = 363 + 9.5, BaP = 345 + 5.3, TCDD =
329 ± 13.5, BeP = 362 ± 1.5, ANTH = 330 + 3.8.
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DISCUSSION

The mobilization o f intracellular Ca2+plays an essential role in signaling pathways
involved in lymphocyte activation, facilitating the transduction of signals from both the T
and B cell antigen receptors to the nucleus (Weiss & Imboden, 1987; Cambier et al.,
1994; Choquet e/a/., 1994). For this reason, it is likely that agents that alter Ca2*
mobilization in immune cells may also disrupt intracellular signaling pathways.
Previous studies conducted in our laboratory have demonstrated that PAHs may exert
their immunomodulatory effects by interfering with intracellular Ca2" homeostasis. We
have shown that in vivo and in vitro exposure to DMBA results in an elevation of baseline
Ca2" in resting cells, and inhibits Ca2" mobilization after PHA stimulation in the Jurkat
human T cell line and murine T cells (Burchiel et al.., 1990, 1991). Using the HPB-ALL
human T cell line, both highly immunosuppressive PAHs, including DMBA and BaP, and
moderately immunosuppressive PAHs, including dibenzo(a,h)anthracene (DAH) and 9,10dimethylanthracene (DMA), have been found to produce a sustained Ca2" elevation for at
least 4 hours, while PAHs that are minimally immunosuppressive, including
dibenzo(a,c)anthracene (DAC), benz(a)anthracene (BA), BeP, and ANTH, produced only
a small and transient (3 minutes) rise in intracellular Ca2" (Krieger et al.., 1995). It
appears that the methylation of anthracene at the 9,10-(DMA) or the 7,12-(DMBA)
positions increased the duration of the Ca2+ elevation suggesting that different PAHs may
affect different constituents of signal transduction pathways in a structure-dependent
manner (Davila et al.., 1995). In the B lymphocyte system, a disruption of baseline Ca2"
has been observed in resting murine splenic B cells and the murine B cell lymphoma A20.1
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cell line after treatment with DMBA (Davis & Burchiel, 1992; Burchiel et al., 1993).
Various PAHs were found to increase tyrosine phosphorylation in A20. 1 (Davila et al.,
1995), and DMBA was also found to induce apoptosis in the murine B cell line (Burchiel
e ta i, 1993).
In this report, we demonstrate that PAHs produce structure-dependent alterations in
Ca2+mobilization in human peripheral blood T and B lymphocytes and monocytes
identified by monoclonal antibodies and flow cytometry in a standard HPBMC
preparation. The effects of the highly immunotoxic PAHs, DMBA and BaP, and TCDD
were compared to anthracene and BeP, which are two PAHs that are relatively non
immunosuppressive in mice (White et al., 1985). In determining the differential sensitivity
of human monocytes, B cells, and T cells to intracellular Ca2* changes produced by PAHs,
we found that a 20 hour exposure to BaP (10 pM) produced a variable degree of
intracellular Ca2+ elevations in B cells and T cells, perhaps due to differences in the
metabolic activity of HPBMC obtained from different donors. The most significant
responses to PAHs appeared to occur following 42 hours or longer exposures, possibly
due to the increased formation of PAH metabolites. In the pooled data obtained from 10
donors, both DMBA and BaP produced a significant increase in intracellular Ca2+ in T
cells, B cells, and monocytes treated for 42 hours, while TCDD produced a significant
Ca2+ response only in B cells. BeP and ANTH did not cause a significant elevation in any
o f the cells populations. These results demonstrate that immunotoxic PAHs, and perhaps
TCDD, produce both a structure and time-dependent increase in intracellular Ca2+ in
HPBMC, but there may be subtle differences in the responses of subsets of lymphoid cells.
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To determine if the alterations of intracellular Ca2+ produced by certain PAHs in
donors could be reproduced and to get some idea of the variability between experiments in
Ca2+ responses, repeat experiments were performed in several donors. In one
representative experiment (n = 3 using different individual donors) using a donor studied
at a 6 month time interval, DMBA and BaP (10 pM) produced a significant elevation in
Ca2+ in the T and B cell populations treated for 42 hours. TCDD (0.1 pM), however,
produced a significant (p < 0.05) Ca2+ response in the monocyte population in the first
experiment but not second, performed approximately 6 months later.
The effects of TCDD, an environmentally persistent contaminant formed as a by
product in the manufacture of herbicides (Esser, 1994), on B cell Ca2+ levels seen in the 10
donor pooled data are potentially interesting, based upon the hypothesis presented by
Holsapple that this agent may disrupt Ca2+ homeostasis in B cells (Karras & Holsapple,
1994; Holsapple et al., 1996). Current evidence suggests that PAHs and perhaps TCDD
produce immunotoxicity by both Ah receptor (AhR)-dependent and independent
mechanisms (Luster e ta i, 1987; Holsapple et al., 1991). We observed a small, but
statistically significant difference in the response of human B cells to TCDD in the present
studies. It is unclear at the present time whether these differences are due to AhRdependent or independent factors. However, it is notable that we have recently observed a
marked difference in the expression of AhR by HPBMC T cells and B cells with T cells
lacking significant expression of mRNA for AhR detected using RT-PCR (Mounho et al.,
1996). Future studies will evaluate the potential role of AhR in PAH-induced signaling in
human lymphocytes. These results demonstrate the variability in PAH responses to
HPBMC that can be expected from normal donors.
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As a general rule, PAHs that are carcinogenic are typically immunosuppressive, while
non-carcinogenic PAHs are generally non-immunosuppressive (White & Holsapple, 1984;
Ward et al.., 1985). This information suggests that both PAH-induced immunotoxicity
and carcinogenicity may involve common mechanism(s). Evaluating PAHs that are
structurally similar, but vary in levels of immunotoxicity, may provide insight in identifying
specific structural moieties responsible for the toxicity o f a particular compound or class
of compounds.
In summary, these studies have demonstrated that known immunotoxic PAHs/HAHs,
such as DMBA and BaP, produce alterations in Ca2+ mobilization in human peripheral T
cells, B cells, and monocytes. These results provide further evidence that intracellular
Ca2+ elevation produced by PAHs/HAHs may be an important mechanism associated with
PAH/HAH-induced immunosuppression.
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CHAPTER O

The Potential Role of Cytochrome P4S0 Metabolism in Polycyclic Aromatic
Hydrocarbon-Induced Alterations in Intracellular Calcium Homeostasis in Human
B Lymphocytes

BACKGROUND AND SIGNIFICANCE

It has been known for at least 30 years that PAHs, such as DMBA BaP, and 3-MC
are immunosuppressive to both rodent and human lymphocytes (Mudzinski, 1993; White
eta l., 1994; Davila et al., 1996). However, the biochemical mechanism(s) by which
PAHs produce immunosuppression has not been definitively established. Using structureactivity relationships, it has been demonstrated that there is a correlation between PAH
immunotoxicity and carcinogenicity. White and Holsapple (1984), for example, have
shown in mice that two noncarcinogenic PAHs (BeP and anthracene) are not
immunosuppressive, whereas carcinogenic PAHs suppress the in vivo IgM antibodyforming colony response (AFC) to sheep red blood cells (SRBC). This relationship has
also been observed using in vitro splenocyte cultures (Dean et al., 1983; White &
Holsapple, 1984; Ward eta l., 1985; Dean e ta l , 1986).
While the relationship between immunotoxicity and carcinogenicity of PAHs has been
noted by previous investigators, it is unclear whether there are common biochemical
mechanisms which may be responsible for both effects. Therefore, a question that could
be posed is whether the mechanism of cancer induction is related to the mechanism of
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immunosuppression. This is a relevant question to address since the mechanism by which
PAHs produce cancer has been more extensively studied that the mechanism by which
PAHs produce immunosuppression.
For cancer induction, it is well known that PAHs must be metabolized by cytochrome
P450 to reactive metabolites which are capable of interacting with DNA (Miller, 1970;
Thakker et al., 1985). The metabolism o f BaP occurs primarily in the bay region
(Macleod et al., 1982) and the ultimate carcinogen of BaP is believed to be BaP-7,8 -diol9,10-epoxide (Dipple, 1994). In contrast, little or no bay region metabolism has been
shown to occur in BeP. The lack of bay region metabolism of BeP, therefore, may explain
the noncarcinogenic properties of BeP compared to its carcinogenic congener, BaP
(Macleod et al., 1982).
In order to determine if the suppressive actions of PAHs on lymphoid cells is mediated
by the parent compound or by the reactive metabolites of PAHs, in vitro studies using
splenocyte cultures have been performed. While both DMBA and BaP exposure resulted
in the suppression of the AFC response to SRBC, the BaP-7,8 -diol and DMBA-3,4-diol
metabolites were found to be more immunosuppressive that the parent compounds
(Kawabata& White, 1987; Ladies etal., 1991). Therefore, these studies provide some
initial evidence that PAH metabolites may be responsible for the immunotoxicity of certain
PAHs.
An alternative approach to examine the influence of PAH metabolism on
immunotoxicity is to utilize a P450 inhibitor that blocks the formation of these
metabolites. One such agent, a-naphthoflavone (ANF), has previously been shown to
inhibit P450 lAand 1B1 activity (Goujon et al., 1972; Santostefano et al., 1992;
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Masubuchi et a l 1994; Bowes et al., 1996). Kawabata and White (1987) have shown
that ANF inhibits the immunotoxicity of BaP in mice. Our laboratory, and others, have
also demonstrated in HPBMC in vitro that T cell mitogenesis is suppressed by BaP and
DMBA, and that this suppression is reversed by ANF (Mudzinski, 1993; Davila et al.,
1996). These results also support the concept that reactive metabolites of DMBA and
BaP play a role in the immunosuppressive effects of these agents. However, while these
results suggest that P450 metabolism may be necessary for the immunotoxicity of certain
PAHs, the interpretation of these findings is complicated by the fact that ANF is also a
partial antagonist o f the cytosolic aromatic hydrocarbon receptor (AhR) (Merchant et al.,
1993; Wilhelmssone ta l., 1994).
Our laboratory has previously shown a strong correlation between the ability of PAHs
to alter Ca2+ homeostasis and to suppress mitogen and antibody responses in murine and
human lymphocytes (Burchiel et al., 1988; Krieger et al., 1994; Davila e t a l , 1996).
While most of our previous work has focused on the effects o f PAHs on human T cells, it
is clear from Chapter 1 that PAHs also exert important effects on intracellular Ca2"
homeostasis in human B cells and monocytes. These Ca2+ modulations, however, have not
been well-characterized. The effects of PAHs on B cells may be especially critical since
humoral immunity, a B cell-dependent response, is known to be the most sensitive immune
response inhibited by PAHs (Davila et al., 1995).
In the present chapter, studies were pursued to define the relationship between
intracellular Ca2= elevation produced by BaP and two important P450-derived metabolites,
BaP-7,8 -diol and BaP-7,8-diol-9,10-epoxide. In addition, the effects of ANF on BaP and
BaP metabolite-induced Ca2+ elevation in HPBMC lymphocytes and monocytes, and
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Daudi human B cells were also evaluated. The goal of these studies was to provide initial
evidence that immunosuppression produced by BaP metabolites, and its reversal by ANF,
can be correlated with effects on intracellular Ca2* homeostasis in human lymphocytes, and
more specifically in human B cells
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MATERIALS AND METHODS

Reagents. Benzo(a)pyrene (BaP), benzo(e)pyrene (BeP), and a-naphthoflavone (ANF)
(purchased from Sigma Chemical Co., St. Louis, MO), and the BaP metabolites,
benzo(a)pyrene-r-7,/-8-dihydrodiol-/-9,10-epoxide(+/~) (anti) (BaP-7,8-diol-9,10epoxide) and benzo(a)pyrene-trans-7,8-dihydrodiol(+/-) (BaP-7,8-diol) (purchased from
the NCI Repository, Midwestern Research Institute, Kansas City, MO) were greater than
95% purity as assessed by the manufacturer. The molecular formula of BaP-7,8 -diol is
C20H 14O2 (m.w. = 286.3) and for BaP-7,8-diol9,10-epoxide is C20HUO3 (m.w. = 302.3).
All PAHs and ANF were dissolved in fresh, sterile, tissue culture grade (> 99% purity)
anhydrous dimethylsulfoxide (DMSO; Sigma), which also served as the solvent control.
All compounds were prepared and used under protective yellow light and visually
inspected to affirm that the compounds were completely dissolved. After BaP metabolites
were dissolved in DMSO, the compounds were aliquoted and stored under nitrogen gas in
glass vials at -20° C until use. The final concentration of DMSO in all cell cultures was <
0. 1%. Cultures containing DMSO did not differ from controls without DMSO, and it was
concluded that at this concentration, DMSO did not produce any measurable effect on
intracellular Ca2+ responses.
Preparation o f H um an Peripheral M ononuclear Cells (HPBMC). Human
peripheral blood was obtained from the Clinical Research Center (CRC) at the University
of New Mexico Hospital in Albuquerque, NM. Volunteer donors were clinically normal
prescreened adults and the isolation of normal human peripheral blood mononuclear cells

47

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

is previously described in Chapter 1. Viability, which ranged from 95 - 99%, was assessed
by trypan blue dye (Sigma) exclusion.
Establishing an in vitro M odel o f H um an B Cell Activation. Since a high degree of
variability was previously observed in Chapter 1 using HPBMC, a human B cell line was
chosen as a model in these studies in parallel with the HPBMC assays. In order to define
an appropriate human B cell line suitable for the Ca2+ mobilization and ANF studies,
several human B cell lines were evaluated, including NCI-BL2126, and the Burkitt’s
lymphoma lines, Ramos, Raji, and Daudi cell lines (all purchased from ATCC, Rockville,
MD). All cell lines were cultured according to ATCC protocol. In separate and individual
experiments, cells from each cell line were treated with either DMBA, BaP, or BeP for 18
hours, and alterations in free intracellular Ca2* were measured as described below. The
Ramos cells were unable to retain Fura Red within the cytoplasm, resulting in a highly
fluorescent but calcium-insensitive data that was inconsistent and variable. The NCIBL2126 and Raji cell lines are characteristic of growing in cell clumps, which made flow
cytometric analysis difficult since the flow cytometer reads individual cells one at a time,
rather than populations. The cell clumps would often block the flow cytometer lines, in
which the experiment would be terminated until the lines were flushed clean. Additionally,
the NCI-BL2126 cell line is an EBV transformed lung carcinoma line, and therefore,
considered an extremely hazardous cell line. The Daudi B lymphoblastoid cell line grows
as single cells in suspension and retains Fluo-3 and Fura Red Ca2* indicators and,
therefore, are ideal cells for flow cytometric analysis. The Daudi cell line is a mature B cell
line that is surface Igm+ and derived from a patient with Burkitt’s lymphoma (Klein et al.,
1968; Kuwahara et al., 1993). This cell line behaves as normal B cells with regard to B
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cell receptor-mediated signaling events, including phosphatidylinositol turnover,
mobilization of intracellular Ca2+, and tyrosine phosphorylation o f proteins (Carter etal.,
1991; Yamanashi et al., 1992; Brent, et al., 1993). Our laboratory has also recently
demonstrated that Daudi cells express both cytochrome P450 1Al and 1A2 (unpublished
data), which are two P450 isozymes involved in the metabolism o f PAHs.
Cell Culturing Conditions o f Daudi cells. Daudi B lymphoblastoid cells were
maintained at 37° C (5% CO 2) in RPMI-1640 (Sigma) supplemented with 20% fetal
bovine serum (Sigma), 2 mM L-glutamine, and 1% penicillin-streptomycin (stock = 10
U/100 ml pen, 10 mg/lOOml strep; Sigma).
Treatment o f Cells. In all intracellular Ca2+ studies using Daudi cells, 106/ml cultured
cells were incubated in the presence of different amounts of PAHs (1.0 - 10.0 pM), ANF
(0.3 - 3.0 pM), or DMSO, the vehicle control. The incubation periods and treatment
conditions varied in the different assays and they are given in the Results and Figure
Legends. For ANF studies using the Daudi cell line, cells were pretreated with ANF for 4
hours and then treated with PAHs. Based on previous studies (Kawabata & White, 1987;
Ladies et al., 1991; Bowes et al., 1996) and studies performed in our laboratory
examining the effects of ANF pretreatment (0.5 - 4 hours) in Daudi, optimal reduction in
the Ca2+elevation produced by PAHs occurred at the 4 hour pretreatment. Therefore, the
4 hour pretreatment time was used in all subsequent ANF studies in the Daudi cell line.
For the ANF studies using normal human HPBMC, BaP (10 pM) was added to isolated
HPBMC (plated a 1 x 106 cells/ml) alone or in combination with 10 pM ANF.
Measurement o f Calcium using Flow Cytometry. Alterations in free intracellular
Ca2* produced by PAHs were measured using Fluo-3 and Fura-Red acetoxymethyl esters
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(Molecular Probes, Eugene, OR), and a Coulter ELITE flow cytometer (Hialeah, FL) as
previously described in Chapter I. Treated cells were harvested, centrifuged, and
resuspended in complete medium containing 13 pM Fura-Red and 6 pM Fluo-3 in a
volume of 100 pi and incubated at 37° C for 1.5 hours, with cells being resuspended *
every 20 minutes to ensure even dye loading. To compare the effects of BaP in gatedlymphocytes and monocytes, the specific cell populations were identified based on forward
and side scatter flow cytometric parameters. The forward scatter (1.5°-19°)° measures the
cell size while the side scatter (90°) measures the granularity o f the cells. Monocytes are
larger and more granular than lymphocytes and, therefore, can be easily targeted using
these flow cytometric parameters. To compare the effects of PAHs on intracellular Ca2*
in human peripheral B lymphocytes, PAH-treated HPBMCs were incubated with the Ca2'
indicators, followed by an incubation for an additional 30 minutes with a phycoerythrin
(PE)-conjugated murine monoclonal antibody at 1 pg/1 x 106 cells to CD 19 (a surface
marker for B cells) as previously described in Chapter 1. Results are shown as the change
in the Mean Channel Fluorescence Ratio (MCFR), which is obtained by subtracting the
MCFR of DMSO vehicle controls from the MCFR of PAH-treated samples. The MCFR,
therefore, represents the elevations in intracellular Ca2+ produced by the PAHs. As
described in Chapter 1, thapsigargin (1 pM) (Sigma) was used in all experiments to ensure
cells, chelators, and flow cytometry detection systems were functioning correctly.
Statistical Design and A nalysis SigmaStat statistical software (Jandel Scientific, San
Rafael, CA) was utilized to analyze data for statistical differences between DMSO control
and treated samples as previously described in Chapter 1. Statistically significant samples
were defined as p < 0.05.
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RESULTS

Elevation o f intracellular Ca2+by BaP in human lymphocytes and monocytes and
its prevention by a-naphthoflavone (ANF). To determine the effects of BaP on
intracellular Ca2+ levels in HPBMC, cells were treated for 18 or 36 hours with 10 pM BaP
and were then analyzed for changes in intracellular Ca2+ using flow cytometric analysis in
light-scatter gated lymphocytes (T and B cells) and monocytes. While in the past our
laboratory has focused on the effects of PAHs at early time points, in these studies we
were interested in evaluating the effects of these compounds at longer exposures, 18 and
36 hours. As shown in Figure 8 , BaP produced a statistically significant (p < 0.05)
increase in intracellular Ca2+ in HPBMC lymphocytes at 36 hours and a trend toward an
increase at 18 hours. The increase in intracellular Ca2+ produced by BaP was significantly
(p < 0.05) blocked by coexposure ofHPBMC to BaP with an equimolar (10 pM)
concentration of ANF. While the effects of ANF are very dose dependent (Wilhelmsson et
al., 1994), in these HPBMC coincubation studies, optimal reduction of PAH-induced Ca2*
elevation by ANF occurred at 10 pM. Figure 9 shows BaP-induced elevations in
intracellular Ca2+ in HPBMC (obtained from the same donor) monocytes identified using
flow cytometry. At 18 and 36 hours, BaP produced a statistically significant (p < 0.05)
elevation in intracellular Ca2+ in HPBMC monocytes, and this increase in Ca2+ produced
by BaP was significantly (p < 0.05) blocked by ANF. Since ANF is a known P450
inhibitor and was found to block the BaP-induced Ca2+ increase seen in HPBMC
lymphocytes and monocytes, these results provide initial evidence that BaP-induced Ca2
elevation in HPBMC may somehow involve cytochrome P450. Values for Figures 8 and 9
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Figure 8. BaP increases intracellular Ca2+ in human peripheral blood lymphocytes
identified using flow cytometry. HPBMC were treated with 10 pM BaP for 18 or 36
hours in the presence or absence of 10 pM a-naphthoflavone (ANF). Results are
shown as the change in Ca2+ Mean Channel Fluorescence (Fluo-3/Fura Red) Ratios
(MCFR) obtained by subtracting the MCFR for DMSO control from the MCFR of
PAH-treated samples. BaP was found to produce a statistically significant increase in
Ca2+ at 36 hours (p < 0.05), and ANF was found to reverse this Ca2+ effect of BaP.
■
“Indicates significant (p < 0.05) increase in intracellular Ca2+ compared to DMSO
solvent control. §Indicates BaP + ANF produced a significant (p < 0.05) reduction in
intracellular Ca2+ compared to BaP alone. Actual MCFR of DMSO (18 hrs) = 316 +
7.6, and at 36 hrs DMSO = 250 + 5.2.

52a

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Lymphocytes
40

BaP

A N F H BaP + ANF

Change in MCFR

30

I

20

10

18 Hrs

36 Hrs

52b

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 9. BaP-induced elevation in intracellular Ca2+ in human peripheral blood
monocytes identified using flow cytometry. HPBMC were treated with 10 pM BaP
for 18 or 36 hours in the presence or absence of equimolar concentrations of anaphthoflavone ANF. Results are shown as the change in Ca2+ MCFR as previously
described. BaP produced a statistically significant increase in Ca2+ at both 18 and 36
hours (p < 0.05), and ANF reversed the Ca2* elevation produced by effect BaP.
*Indicates significant (p < 0.05) increase in intracellular Ca2+ compared to DMSO
solvent control. ^Indicates BaP + ANF produced a significant (p < 0.05) reduction in
intracellular Ca2+ compared to BaP alone. Actual MCFR o f samples haviing a change
in MCFR < 0 is as follows: 18 hrs: DMSO = 368 + 13.8; 36 hrs: DMSO = 327 +
12.3, ANF = 325 + 9.7.
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are the means for quadruplicate determinations + S.D. for a single donor (note: these data
are representative of experiments repeated 3 times using different donors).
Intracellular Ca*+Elevation by BaP Metabolites in Daudi H um an B Cells. Daudi
cells were treated with either BaP, BaP metabolites, or BeP for 1, 4, or 18 hours.
Alterations in free intracellular Ca2+ were measured by multiparameter flow cytometric
analysis using the Ca2+-chelating dyes, Fluo-3 and Fura-Red. In previous studies
determining a dose-response relationship, it was found that a 10 pM concentration of
BaP-7,8-diol and especially BaP-7,8-diol-9,10-epoxide killed most o f the cells, while at a
1 pM concentration, the Ca2+ response often did not occur. A 3 pM concentration,
however, produced a consistent and optimal Ca2+response, and for this reason, was the
concentration used in these studies. Both BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide at
3 pM concentrations produce a significant (p < 0.05) elevation in intracellular Ca2+
compared to DMSO vehicle control at 1 (Figure 10), 4 (Figure 11), and 18 (Figure 12)
hours. The various time points were chosen to observe if there was a time-dependent
effect of the BaP metabolites on intracellular Ca2+in the Daudi cell line. At 10 pM
concentrations, both the parent compound, BaP, and BeP, a nonimmunotoxic PAH, did
not produce a significant rise in Ca2+ at any of the time points. Results are shown as the
change in the MCFR as previously described and values shown are means for
quadruplicate determinations ± S.D.
Reduction o f BaP metabolite-induced intracellular Ca2+elevation by anaphthoflavone (ANF) in Daudi. To further investigate the potential role of P450 in
PAH-induced Ca2+ elevations and immunosuppression, the effects o f ANF on BaP
metabolite-induced Ca2+ elevation were examined. Daudi cells were pretreated for 4 hours
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Figure 10. Intracellular Ca2+ Elevation by BaP Metabolites in Daudi Human B Cells
treated for 1 hour. Daudi cells were treated with either BaP or BeP at 10 pM
concentrations, or BaP-7,8-diol, BaP-7,8-diol-9,10-epoxide, at 3 pM concentrations.
Free intracellular Ca2+ was measured by multiparameter flow cytometric analysis using
the Ca2"-chelating dyes Fluo-3 and Fura Red. Results of alterations in intracellular
Ca2+concentrations are shown as the change in the MCFR and values are means for
quadruplicate determinations + S.D. *Indicates significant (p < 0.05) increase in free
intracellular Ca2+ compared to DMSO vehicle control. Actual MCFR of samples
having a change in MCFR < 0 is as follows: DMSO = 228 + 2.7, BaP = 227 + 1.3,
BeP = 225 + 1.5.
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Figure 11. Intracellular Ca2+ Elevation produced by BaP Metabolites in Daudi Human
B Cells treated for 4 hours. Daudi cells were treated with either 10 pM BaP or BeP,
or BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide at 3 pM concentrations. Free
intracellular Ca2+ was measured by multiparameter flow cytometric analysis and results
o f alterations in intracellular Ca2+ concentrations are shown as the change in MCFR as
previously described. Values are means for quadruplicate determinations ± S.D. and
•indicates significant (p < 0.05) increase in free intracellular Ca2* compared to DMSO
vehicle control. Actual MCFR of DMSO = 232 + 5.9 and BeP = 228 + 4.3.
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Figure 12. Elevations in intracellular Ca2+ by BaP Metabolites in Daudi Human B Cells
treated for 18 hours. Daudi cells were treated with either 10 pM BaP or BeP, or BaP7,8-dioI and BaP-7,8-diol-9,10-epoxide at 3 pM concentrations. O f the three time points
evaluated (1,4, and 18), the maximal Ca2+ response occurs at the 18 hour time point. Free
intracellular Ca2+ was measured by multiparameter flow cytometric analysis and results of
alterations in intracellular Ca2+concentrations are shown as the change in MCFR as
previously described. Values are means for quadruplicate determinations ± S.D. and
indicates significant (p < 0.05) increase in free intracellular Ca2+ compared to DMSO
vehicle control. Actual MCFR of DMSO = 254 +2.0 and BeP = 253 + 3.4.

57a

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

100

18 hours

CHANGE IN MCFR

75 -

50 -

25 -

*

A '
*

t

J

*

57b

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

with ANF, and were then treated for 18 hours with the BaP metabolites, BaP-7,8-diol and
BaP-7,8-diol-9,10-epoxide. In separate experiments, pretreatment with ANF for 4 hours
was found to give optimal inhibition o f the Ca2+ elevation produced by PAHs in Daudi
cells. Figure 13 demonstrates the dose-response trend of various concentrations of ANF
(0.3 pM - 3 pM) that produce the largest reduction in the intracellular Ca2+ elevation
produced BaP-7,8-diol (3 pM). Alone, ANF does not produce a significant response at
any o f the concentrations used. P450 inhibition by ANF pretreatment significantly (p <
0.05) reduced the rise in Ca2+ produced by BaP-7,8-diol, with the greatest reduction
occurring at the 0.3 pM concentration. For this reason, this concentration o f ANF used in
all subsequent experiments. While pretreatment with 0.3 pM ANF completely blocks the
BaP-7,8-diol-induced Ca2* elevation, ANF had no effect on the Ca2+ response produced by
BaP-7,8-diol-9,10-epoxide (Figure 14; a separate representative experiment o f 5 assays).
The fact that ANF had no effect on BaP-7,8-dioI-9,10-epoxide-induced Ca2+ elevation was
expected since it is the final P450-derived BaP metabolite in this pathway and does not
require further P450 metabolism to be active (Figure 15). These results provide some
preliminary evidence that of the two BaP metabolites examined, it is BaP-7,8-diol-9,10epoxide that predominantly and directly alters intracellular Ca2+ in B cells. BaP never
produced a statistically significant rise in intracellular Ca2+ at 1, 4, or 18 hours in the
Daudi cell line, and for this reason, the effects of ANF on BaP-induced Ca2+ elevation in
Daudi cells was not examined. Results in Figure 14 are shown as the change in the MCFR
and values shown are means for quadruplicate determinations + S.D.
BaP Metabolites elevate intracellular Ca*+in normal HPBMC B lymphocytes. In
observing that both the BaP metabolites, BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide,

58

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 13. Dose-response o f the reduction o f BaP metabolite-induced intracellular Ca2+
mobilization by a-naphthoflavone (ANF) in Daudi. Daudi cells were pretreated for 4
hours with either 0.30, 1, or 3 pM ANF, and then treated for 18 hours with BaP-7,8-diol
at 3 pM. Free intracellular Ca2+ was measured using flow cytometry and results are shown
as the change in the MCFR. Values are means for quadruplicate determinations ± S.D.
^Indicates significant (p < 0.05) increase in free intracellular Ca2+ compared to DMSO
vehicle control. §Indicates a significant (p < 0.05) reduction in intracellular Ca2+ by ANF
pretreatment compared to PAH-treatment alone. Actual MCFR of DMSO = 265+ 12.4
and .3 pM ANF = 259 ±6.1.
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Figure 14. Inhibition of BaP-7,8-diol- but not BaP-7,8-dioI-9,10-epoxide-induced Ca2~
by ANF. Daudi cells were pretreated for 4 hours with 0.30 pM ANF, followed by
treatment with BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide at 3.0 pM for 18 hours. Free
intracellular Ca2+ was measured by multiparameter flow cytometric analysis using the
Ca2+-chelating dyes Fluo-3 and Fura Red. Results of alterations in intracellular Ca2+
concentrations are shown as the change in the MCFR and values are means for
quadruplicate determinations ± S.D. *Indicates significant (p < 0.05) increase in free
intracellular Ca2* compared to DMSO vehicle control. §Indicates a significant (p < 0.05)
reduction in intracellular Ca2+ by ANF pretreatment compared to PAH-treatment alone.
Actual MCFR for samples having a change in MCFR < 0 is as follows: DMSO = 235 +
1.8, ANF = 226 ± 5.0, 7,8-diol/ANF = 230 ± 4.0.
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Figure 15. The metabolism of benzo(a)pyrene (BaP) by cytochrome P450. BaP, the
parent compound, is metabolized by P450 to the BaP-7,8-oxide, which is then converted
to the BaP-7,8-diol by epoxide hydrolase. The BaP-7,8-diol is then metabolized by P450
to the BaP-7,8-diol-9,10-epoxide, which is the last P450-derived metabolite in this
pathway. Adapted from: White et al., (1994). Immunotoxicology and
Immunopharmacology, 2nd Edition, Figure 1, p. 127.
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significantly elevated free intracellular Ca2+ in Daudi human B cells, we were interested in
determining if these metabolites would produce the same Ca2+ response in normal human
peripheral B lymphocytes. Alterations in intracellular Ca2+ were measured using flow
cytometric analysis as previously described and CD19+ positive B cells were identified
using a PE-conjugated monoclonal antibody to CD 19 cell surface antigens. A doseresponse relationship o f the two BaP metabolites is shown in Figure 16. Results are
shown as the change in the MCFR as previously described, and values shown are means
for quadruplicate determinations + S.D. for a single donor (representative of n = 3). In
this donor at 18 hours, neither BaP or BeP (10 pM) produced a significant rise in
intracellular Ca2+. Both BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide significantly (p <
0.05) elevated intracellular Ca2*levels at 1 pM compared to DMSO controls, and the
magnitude of the Ca2+ elevation was even greater at 3 pM. The 3 pM concentration,
therefore, was used for the remaining HPBMC studies. Figure 17 shows the Ca2*
elevation in HPBMC CD19+B lymphocytes in a different donor. As in the previous
donor, BaP and BeP at 10 pM did not produce a significant Ca2+ rise, whereas both Bap7,8-diol and BaP-7,8-dio 1-9,10-epoxide (3 pM) significantly (p < 0.05) elevated
intracellular Ca2+ compared to DMSO controls. These data suggest that certain BaP
metabolites, particularly BaP-7,8-diol-9,10-epoxide, do have a direct effect on intracellular
Ca2+ homeostasis in normal human B lymphocytes.
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Figure 16. Intracellular calcium elevation in normal human peripheral blood B cells
(CD 19*) treated for 18 hours. Mononuclear cell cultures were treated with either 10
pM BaP or BeP, or BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide at 1.0 and 3.0 pM
concentrations. Alterations in intracellular Ca2+ were measured using flow cytometric
analysis as previously described and CD19+ positive B cells were identified using a
PE-conjugated monoclonal antibody to CD 19 cell surface antigens. Results are shown
as the change in the MCFR and values are means for quadruplicate determinations ±
S.D. for a single donor. ““Indicates significant (p < 0.05) increase in free intracellular
Ca2+ compared to DMSO solvent control. Actual MCFR o f DMSO = 223 ±2.5.
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Figure 17. Intracellular calcium elevation in normal human peripheral blood B cells
(CD 19^ treated for 18 hours. Mononuclear cell cultures were treated with either 10 pM
BaP or BeP, or BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide at 3.0 pM concentrations.
Alterations in intracellular Ca2+ were measured using flow cytometry and the Ca2+chelating dyes, Fluo-3 and Fura Red and CD19+ positive B cells were identified using a
PE-conjugated monoclonal antibody to CD 19 cell surface antigens. Results are shown as
the change in the MCFR and values are means for quadruplicate determinations + S.D. for
one donor. *Indicates significant (p < 0.05) increase in free intracellular Ca2~ compared to
DMSO solvent control. Actual MCFR of DMSO = 199 + 6.0.
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DISCUSSION
Several cytochrome P450 enzymes are involved in PAH metabolism and bioactivation
and it is well recognized that the carcinogenic actions of BaP and other PAHs are
mediated by P450-derived metabolites (Ladies et al., 1992a, 1992b; White etal., 1994;
Bauer et al., 1995; Shimada et al., 1996; Kress & Greenlee, 1997). In studies examining
the role of various P450s catalyzing the activation of different procarcinogenic chemicals,
P450 1A1, 1A2, 3A4 and 1B1 were all shown to exhibit activity in the metabolism of
certain PAHs (Bauer et al., 1995; Shimada ef al., 1996). It has been shown that BaP
induces cytochrome P450 levels (Ladies et al., 1992b; Sterling et al., 1994) and the
carcinogenic and mutagenic actions of BaP and many other PAHs are known to be
mediated by their reactive metabolites (Gelboin et al., 1980; Osbome & Crosby, 1986).
While the characterization of cytochrome P450 isozymes involved in PAH activation
has been primarily documented in rat hepatic microsomes, relatively little information is
available regarding the bioactivation of PAHs in human tissues (Shimada et al., 1989;
Borlakoglu et al., 1993). Jerina et al. (1984), have shown in rat hepatic microsomes that
BaP is metabolized by P450 1Al to BaP-7,8-oxide which is then hydrated to BaP-7,8-diol
by epoxide hydrolase. Further metabolism by P450 I Al results in the formation of Bap7,8-diol-9, 10-epoxide. Recent studies, however, have demonstrated that other P450
isozymes are also involved in the metabolism of PAHs, including P450 1A1, 1A2, 1B1,
and 3A4 (McManus etal., 1990; Bauer et al., 1995; Shimada etal., 1996). While P450
1Al is primarily expressed in extrahepatic tissues and 1A2 is principally found in the liver,
both of these P450 isozymes predominantly participate in the bioactivation of PAHs
(Tuteja etal., 1985; Shimada et al., 1992, 1994). P450 1A1 is known to be expressed
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and active in HPBMC following treatment with T cell mitogens and it has been
demonstrated that human lymphocytes are capable of converting pre-carcinogenic
hydrocarbons to their reactive forms (Whitlock et al., 1972; Gupta et al., 1988).
Cytochrome P450 3A4, a major P450 isozyme found in human liver, also appears to be
involved in the metabolism of PAHs (McManus etal., 1990; Bauer et al., 1994).
Cytochrome P450 1B1 is a relatively new member of the “1” family, and has been
characterized in rodent and human tissues and is constitutively expressed in several organs
(Savas etal., 1994; Sutter etal., 1994). P450 1B1 has been shown to be inducible by
several environmental carcinogens, including PAHs and TCDD, and just as P450 1A1 and
1A2, is inhibited by ANF (Brake & Jefcoate, 1995; Shimada et al., 1996; Bowes et al.,
1996).
Since previous studies have shown that certain BaP metabolites elevate intracellular
Ca2+ as well as deplete intracellular glutathione in HPBMC, and inhibition of P450 activity
reduces the immunotoxicity of BaP (Davila et al., 1996), we performed a series of
experiments directly examining the effects o f two known immunosuppressive BaP
metabolites on intracellular Ca2* in Daudi human B cells and HPBMC B lymphocytes.
Both o f the metabolites examined, BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide, were
much more effective than the parent compound, BaP, in increasing intracellular Ca2* in
Daudi B cells and in CD19+ human B lymphocytes obtained from normal human peripheral
blood.
BaP-7,8-diol-9,10-epoxide is a bay region diol epoxide and is thought to be the
ultimate carcinogenic metabolite, forming nucleic acid adducts predominantly by reaction
with N2 o f guanine in DNA at the benzylic 10 position (Miller, 1970; Dipple, 1994;

66

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Peltonen & Dipple, 1995). An important characteristic of bay region diol epoxides is their
resistance to hydrolyation by epoxide hydrolase, which is due to the steric hindrance from
the adjacent dihyrodiol group (Parkinson, 1996). Additionally, the reactive metabolites of
BaP are not only capable of DNA adduct formation, but may also covalently bind cysteine
sulfhydryls or amine groups of cellular macromolecules such as proteins or peptides
(Pruess-Schwartz et al., 1986; Pitot & Dragan, 1996; Romero et a l , 1997).
Alpha-naphthoflavone (ANF), is known to inhibit cytochrome P450 isozyme activity,
P450 mRNA transcription, and the metabolism o f BaP (Merchant et a l, 1990; Hardin et
a l, 1992). Additionally, ANF has been shown to antagonize the ability of TCDD to
induce P450 1Al, immunosuppression, and down-regulation of the estrogen receptor
(Goujon e ta l, 1972; Gurtoo e ta l, 1979; Blanket a l, 1987). Proposed mechanisms by
which ANF mediates these effects include 1) competitive inhibition of the AhR, thereby
blocking AhR-substrate translocation to the nucleus, and 2) acting as a metabolic
antagonist to cytochrome P450 activity (Blank et a l, 1987; Gasiewiez & Rucci, 1991;
Ladies e ta l , 1991).
Kawabata and White (1987) have shown that ANF blocks the suppression o f the in
vitro humoral immune response produced by BaP and BaP metabolites in murine
splenocytes. Our laboratory has recently shown that ANF reverses the suppression of T
cell mitogenesis produced by PAHs and certain BaP metabolites (Davila et a l, 1996) and
we have also observed that P450 inhibition by ANF blocks the elevation in intracellular
Ca2+ produced by BaP in nylon wool-purified human peripheral blood T cells (unpublished
data). In the present studies, we found in light scatter-gated HPBMC lymphocytes and
monocytes that the elevation in intracellular Ca2+ produced by BaP was significantly
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inhibited by ANF. Additionally, in Daudi cells, P450 inhibition by ANF pretreatment
completely blocked the elevation o f intracellular Ca2+ produced by BaP-7,8-diol, but had
no effect on the Caz+ rise produced by BaP-7,8-diol-9,10-epoxide, which is the last P450derived metabolite in this pathway. By demonstrating that the Ca2+ elevation produced by
BaP-7,8-diol is completely blocked by ANF, while having no effect on BaP-7,8-diol-9,10epoxide, these data provide some preliminary evidence that cytochrome P450 may be
associated with PAH-induced Ca2+ elevations in human B cells.
Based on the present studies, there are four independent observations which suggest
that BaP metabolites are important in Ca2+elevation, and suggest that HPBMC and Daudi
cells are capable of metabolizing BaP to the reactive diol epoxide, which appears to be
predominantly responsible for elevations in intracellular Ca2+: 1) ANF inhibits BaP and
BaP-7,8-dioI-induced increases in intracellular Ca2+ in HPBMC (lymphocytes and
monocytes) and Daudi, but not the Ca2+ elevations produced by BaP-7,8-diol-9,10epoxide; 2) BaP requires relatively long exposure times ( 4 - 3 6 hours) to produce Ca2*
elevations in Daudi and HPBMC; 3) BaP metabolites are more potent in producing an
increase in intracellular Ca2+ than the parent compound; 4) BaP-7,8-dioI-9,10-epoxide
acts more rapidly in increasing intracellular Ca2+ than BaP in HPBMC B lymphocytes and
Daudi cells. These results further suggest that BaP-7,8-diol-9,10-epoxide is the ultimate
immunotoxicant for Ca2+ elevation and provides a strong correlation with the known
carcinogenicity of this metabolite. Thus, these results suggest that a common P450derived metabolic product of BaP, such as BaP-7,8-diol-9,10-epoxide, may provide a
biochemical association between immunotoxicity and carcinogenicity of this PAH.
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At this time, the relative P450 activity in human lymphocytes and monocytes has not
been definitively established. While it is known that human lymphocytes have P450IA
activity (Whitlock et al., 1972), it is unclear whether lymphocytes have adequate P450
activity to form sufficient concentrations of PAH metabolites to produce immunotoxicity.
In addition, it has not been fully defined if PAH metabolism occurs predominantly via
macrophages present in spleen cell preparations or other mixed cell cultures, such as
HPBMC. For these reasons, our laboratory and others, have evaluated the effects of the
parent compound and the reactive metabolites of PAHs on several potential mechanisms
which may be associated with immunotoxicity (Kawabata & White, 1987; Ladies et al.,
1991; Davila et al., 1996). Researchers have shown that in mixed cultures, macrophages
are the primary class o f immune cells which metabolize PAHs (Okano et al., 1979; Ladies
et a l, 1992b). Therefore, characterizing the relative role of immune cells involved in
P450 metabolism, as well as the kinetics o f P450 induction in various cells, will also need
to be explored in future studies.
Studies have demonstrated that several immunotoxic PAHs, including BaP, bind to the
AhR (Okey et al. 1984; Pliszczynska et a l, 1986; Nebert, 1989). PAHs bind to the AhR
prior to metabolic activation by P450 and, therefore, some investigators postulate that
PAH-induced immunotoxicity is associated with AhR-binding and subsequent activation
of the Ah gene complex (Bast etal., 1974; Silkworth et al., 1984; Wojandi & Alfred,
1984; Thurmond etal., 1988; Waithe et al., 1991; Mudzinski, 1993; Nebert, 1994).
Currently, we do not know whether ANF exerts its effects on AhR in Daudi cells and,
therefore, the role of AhR in Ca2+ signaling can not be excluded. At a minimum, the AhR
may be involved in P450 induction in B lymphocytes and other cells. Investigators have
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also suggested, however, a role for AhR in signaling effects produced by PAHs
(Matsumura et a l 1993). It is probable that both AhR-binding and cytochrome P450
play a role in the immunosuppressive effects of PAHs and, therefore, polymorphisms in
AhR expression and P450 activity may be important factors in determining human health
risks associated with PAH exposure. For these reasons, future work in our laboratory will
continue to investigate the potential association of AhR and cytochrome P450 with PAHinduced Ca2+ elevation and immunotoxicity in human lymphocytes.
Finally, we have not established the mechanism(s) by which PAHs and/or metabolites
cause alterations in intracellular Ca2+ in human B cells. Our laboratory has recently shown
that certain BaP metabolites deplete intracellular glutathione in HPBMC, suggesting that
sulfhydryl attack or covalent binding may be associated with the immunotoxicity of PAHs
(Romero et al., 1997). Based upon previous studies, two potential mechanisms for PAHinduced Ca2+ elevation are likely: 1) activation of Src-related protein tyrosine kinases
(Archuleta et al., 1993) or 2) inhibition of sarcoplasmic/endoplasmic reticulum Ca2+
ATPases (SERCA) (Krieger et al., 1995). The first of these two possibilities was
evaluated in Chapter 3 of this dissertation.
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CHAPTER m

The Potential Association Between PAH-Induced Disruptions in Ca2+ Homeostasis
and Increased Protein Tyrosine Kinase Activity in Human B Lymphocytes

BACKGROUND AND SIGNIFICANCE

There has been an increasing awareness over the past few years that PAHs exert their
immunosuppressive effects by disrupting intracellular Ca2+ homeostasis in lymphocytes
and other immune cells (Davila et al., 1995; Holsapple et al., 1996). In Chapters 1 and 2,
it was demonstrated that certain PAHs, such as BaP, and the BaP metabolites, BaP-7,8diol and BaP-7,8-diol-9,10-epoxide, elevated intracellular Ca2+ concentrations in both
HPBMC CD 19* B lymphocytes and Daudi B cells. PAH-induced alterations in Ca2*
homeostasis in B lymphocytes interrupts antigen receptor signaling that employs free
intracellular Ca2+ as a second messenger. Acting as an important second messenger, Ca2‘
plays a significant role in the regulation of signal transduction pathways (Carafoli, 1987;
Cole&Kohn, 1994).
At this time, the actual molecular mechanisms by which certain PAHs and their
reactive metabolites alter Ca2+ homeostasis and intracellular signaling in B cells have not
been fully defined. One potential mechanism involved in PAH-mediated immunotoxicity
is an increase in Src-family protein tyrosine kinase (PTK) activity. Previous studies
performed in our laboratory have shown that certain PAHs increase both tyrosine kinase
activation and tyrosine phosphorylation of phospholipase C-yl (PLCyl) in HPB-ALL

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(Archuleta et al., 1993). These data suggest that PAHs may alter PTK activity which
ultimately results in the elevation of intracellular Ca2+. In the past, research on PTKs has
focused on understanding their regulation and identifying their substrates. Only in the past
few years have their roles in B cell signal transduction cascades been examined. The
purpose o f the studies presented in this Chapter, therefore, was to evaluate the potential
role of PTKs, including Lyn (a Src-family kinase) and Syk, in PAH-induced intracellular
Ca2+ alterations in human B lymphocytes.
The class of immune cells that is primarily responsible for the humoral immune
response is B lymphocytes. When activated, B cells differentiate into plasma cells that
eliminate extracellular pathogens by way of specific antibodies. Antibodies are
immunoglobulins which have a structure of two low molecular weight (light) polypeptide
chains and two high molecular weight (heavy) polypeptide chains linked by disulfide
bonds. Immunoglobulins are divided into five classes designated IgM, IgG, IgA, IgD, and
IgE. B lymphocytes have membrane-bound immunoglobulins (mlgs) on their surface that
recognize and act as receptors for antigens. Although all immunoglobulin isotypes can act
as surface receptors on mature peripheral B cells, mlgM and mlgD are predominately
expressed (Reth et al., 1991). The B cell antigen receptor (BCR) is a multimeric complex
of membrane immunoglobulin which is noncovalently associated with transmembrane
disulfide-linked heterodimers designated Ig-a and Ig-P (Reth, 1992). The Ig-a
heterodimer has a long cytoplasmic tail containing 61 amino acid residues and tail of Ig-P
contains 48 amino acids (Kuby, 1997). The cytoplasmic tails o f both the Ig-a and Ig-P
proteins contain a conserved sequence motif known as an “immunoreceptor tyrosine based
activation motif’ or ITAM (Sefton and Taddie, 1994; Johnson e ta l., 1995). The ITAM
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sequence consists of 18 amino acid residues and is defined as two tyrosine residues spaced
9 to 11 residues apart with isoleucine or leucine resides positioned three residues carboxyterminal to each tyrosine (Chan & Shaw, 1995). The molecular weight of Ig-a is
approximately 34 kDA and for Ig-P is 42 kDa. Ig-a and Ig-P have been shown to
associate with Syk/ZAP-70 and Src-family kinases and appear to play a role in intracellular
signaling following stimulation of the BCR (DeFranco, 1995). Upon antigen crosslinking
of the BCR, the ITAMs are rapidly tyrosine phosphorylated by Src-family PTKs which
subsequently results in the activation of Src- and Syk-family kinases (Cambell & Sefton,
1992; Clarke/a/.., 1992; DeFranco, 1992; Cambier, 1995; Johnson et al., 1995).
Antigen crosslinking of mlgM or mlgD on mature B cells results in cell proliferation
and activation, while antigen binding by mlgM on immature B cells results in cell death or
inactivation (Nossal, 1983; DeFranco, 1987 Nemazee & Burki, 1989). In both mature
and immature B cells, stimulation of resting B cells via the crosslinking of mlg results in
the phosphorylation and activation of two intracellular signaling pathways: 1) protein
tyrosine phosphorylation and 2) phosphoinositide hydrolysis resulting in the stimulation of
protein kinase C (PKC) and an elevation of intracellular Ca2+ (Coggeshall & Cambier,
1984; Gold etal., 1990; Yamanashi etal., 1992; Harwood & Cambier, 1993). Several
non-receptor PTKs mediate this phosphorylation, including the Src-family and the
Syk/ZAP-70 family o f PTKs (van Oers & Weiss, 1995; Law etal., 1996; Pao &
Cambier, 1997) and several studies utilizing PTK inhibitors have demonstrated that
downstream signaling events in B cells are dependent on tyrosine phosphorylation of
effector proteins (Padeh et al., 1991; Pure' & Tardelli, 1992). Both mlgM and mlgD
have short cytoplasmic tails (only three amino acids) and it is, therefore, highly unlikely
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that these surface receptors directly stimulate intracellular signaling pathways (DeFranco,
1995). It is more conceivable that B cell antigen receptors associate with other proteins to
transduce their intracellular signal to the nucleus.
Crosslinking of the BCR rapidly activates receptor-associated kinases, resulting in an
increase in tyrosine phosphorylation o f numerous cytoplasmic effector proteins
(DeFranco, 1992; Kurosaki e ta l., 1994). After BCR ligation, the activation o f these
receptor-associated kinases is maximal between 15 and 60 seconds, and the resulting
tyrosine phosphorylation of proteins is likely to be one of the earliest events in the mlgmediated signaling cascade (Burkhardt et al., 1991; Pleiman etal., 1994). It appears that
several receptor-associated tyrosine kinases mediate this phosphorylation of effector
enzymes, including the Syk/ZAP-70 family and the Src-family kinases p53/56lyn (Lyn),
p55bUc (Blk), p59fV" (Fyn), and p56,ck (Lck) (DeFranco, 1992; Hutchcroft et al., 1992;
Yamanashi etal., 1992; Pleiman e ta l., 1994). ZAP-70, a 70 kd PTK, is expressed
exclusively in T cells and natural killer (NK) cells, while Syk (72 kd) is preferentially
expressed in B cells, myeloid cells, and thymocytes (Taniguchi et al., 1993; DeFranco,
1995). Both Syk/ZAP-70 and Src-family kinases are characterized by the motif
HRDLAARN, which is exclusively associated with PTKs in addition to important
regulatory sites or Src-homology domains which precede a highly conserved catalytic
domain (Taniguchi et al., 1991; Law et al., 1994).
Spleen tyrosine kinase or Syk was initially purified from bovine thymus and is a 72 kDa
non-receptor protein tyrosine kinase abundantly expressed in B lymphocytes (Taniguchi et
al., 1991). The structure homology o f Syk is very similar (approximately 73% amino acid
sequence homology) to ZAP-70 (zeta-associated protein), which is found primarily in T
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cells. Syk has two Src-homology 2 (SIC) domains (110 amino acids) which are important
regulatory sites that mediate protein-phosphoprotein interactions and serve as binding sites
for other intracellular signaling proteins (Koch eta l., 1991). The SH2 domain recognizes
a sequence motif consisting of a region of amino acids containing a phosphorylated
tyrosine residue which, in conjunction with the surrounding residues, determines the
specificity of these interactions (Pawson & Schlessinger, 1993; Zhou et al., 1993).
Unlike Src-family kinases, Syk has no SID regulatory domain, no negative regulatory
COOH-terminal tyrosine phosphorylation site, and no sites o f N-myristylation. Therefore,
Syk is probably not constitutively localized in the plasma membrane (Weiss & Littman,
1994). The conserved catalytic site of Syk consists of a glycine-rich motif and a
downstream lysine residue, and the glycine residues form a loop and anchor the
phosphates of ATP while lysine binds the nucleotide (Knighton eta l., 1991). Although
the phosphorylation sites in Syk have not been definitively identified, it appears that Syk
contains four tyrosine phosphorylation sites with the autophosphorylation motif of Syk
comprising of the amino acid sequence YKAQ representing residues 526-529 (Watts et
al., 1994). Syk coimmunoprecipitates with components of the BCR, suggesting that Syk
is associated with mlg complexes (Hutchcroft ef a l, 1992; Cooper & Howell, 1993).
Upon mlg receptor crosslinking and ITAM phosphorylation, Syk is rapidly tyrosine
phosphorylated by a Src-family kinase which leads to the spatial reorientation,
recruitment, and clustering of Syk into the receptor complex (Pleiman et al., 1994; Weiss
& Littman, 1994; van Oers & Weiss, 1995). This localization o f Syk (Figure 18) into the
receptor complex is achieved by way of Syk SHE domains binding to doubly tyrosine
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Figure 18. The structure of the B cell antigen receptor (BCR). The BCR is a
complex of membrane immunoglobulin associated with two transmembrane
heterodimers, Ig-a and Ig-p. Immediately upon BCR crosslinking, the
immunoreceptor tyrosine based activation motifs (ITAMs) are tyrosine phosphorylated
by Src-family kinases, which serve as docking sites for the SH2 domains of Syk and
Src kinases. From: Kuby, J. (1997). Immunology 3rdEdition, Figure 8-7, p. 203,
with permission.
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phosphorylated ITAM sequences on Ig-a and/or Ig-P, resulting in the upregulation of Syk
activity (Chan & Shaw, 1995; Rowley et al., 1995; Zoller et a l ; 1997).
Of the Src-family kinases, Lyn and Blk are preferentially expressed in B cells and other
hematopoietic cells, while Fyn and Lck appear to be predominantly expressed in T cells
(Burkhardt et a l, 1991; Yamanashi et al, 1992). The Src-family kinases are associated
with the cytoplasmic region o f the plasma membrane and appear to act as intracellular
signal transducers for surface receptors. While some investigators believe that Lyn and
Blk are physically associated with mlg, others propose that these kinases are actually
associated with components o f the B cell antigen receptor, such as Ig-a or Ig-(3
(Burkhardt etal., 1991; Campbell & Sefton, 1992). Src-family kinases, such as Lyn,
possess one SH2 and one SH3 domain, an inhibitory tyrosine phosphorylation site in the
C-terminal tail (Tyr-527), and a N-terminal myristylation site (Cooper & Howell, 1993;
Sefton & Taddie, 1994). The SH3 domain enables Lyn to bind to proline-rich regions in
other signal transducing proteins such as phosphatidylinositol 3 kinase (Ren et a l, 1993).
In B lymphocytes, the phosphorylation of Ig-a/Ig-3 and Syk kinase is carried out by
Src-family kinases, particularly Lyn (Sefton & Taddie, 1994; Kong et a l, 1996). Studies
using Lyn-negative cells demonstrate that Lyn phosphorylates and modulates the
enzymatic activity of Syk, suggesting that Lyn acts upstream of Syk (Kurosaki et al.,
1994). All Src-family kinases possess two regulatory sites for tyrosine phosphorylation:
one site located in the kinase domain that serves to potentiate kinase activity, and a site
within the COOH-terminal region that functions as a negative regulatory site. The up- and
downregulation of Lyn activity is mediated by the tyrosine phosphorylation/
dephosphorylation of these specific regulatory sequences. The transmembrane tyrosine
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phosphatase, CD45, activates Lyn kinase through the dephosphoryiation of a specific
tyrosine residue (Tyr527) in the negative regulatory COOH-terminal region (Koretzky,
1993; Burg e ta l., 1994; Justement et al., 1994; Thomas, 1994). Alternatively, the
catalytic activity o f Lyn kinase is inhibited by Csk kinase, which phosphorylates Tyr527 in
the negative COOH-terminal domain (Erpel & Courtneidge, 1995). The
autophosphorylation of Tyr416 within the catalytic domain of Lyn is also a main
contributor to the upregulation of Lyn activity (Chan & Shaw, 1995).
It is well recognized that BCR cross-linking activates both Lyn and Syk tyrosine
kinases which subsequently results in the activation o f several second messenger
pathways. Syk couples the BCR to the phosphatidylinositol/Ca2" pathway through the
direct phosphorylation and activation of PLC-y, and in Daudi human B cells, Syk
phosphorylates PLCyl on Tyr77, the major regulatory residue of PLCy, and Tyr783
(Sillman & Monroe, 1995; Law etal., 1996). Takata etal. (1994) has demonstrated in a
Syk-negative cell line that the crosslinking of the BCR does not activate the PLCydependent release of intracellular Ca2+, which also supports the concept that Syk is
involved in the activation of PLCy. Once activated by Syk, PLCy catalyses the breakdown
of membrane phosphoinositides into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol
(DAG) (Leprince et al., 1992; Richards et al.. 1996). EP3 subsequently binds to the IP3
receptor located on the membrane of the endoplasmic reticulum which stimulates the
mobilization of free intracellular Ca2~ into the cytosol (McConnell et al., 1992; Jayaraman
etal., 1996).
In addition to the mobilization of intracellular Ca2+, the activation of both Syk and Lyn
kinases results in the tyrosine phosphorylation of numerous effector proteins, including
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GTPase-activating protein (GAP), phosphoinositide 3-kinase (PI 3-kinase), and mitogenactivated protein kinase (MAPK) (Yamanashi et al., 1992; Kuruvilla et al., 1993). These
effector proteins are constituents of downstream signal transduction pathways intimately
involved in B cell growth and activity. Activation of PTKs is a fundamental process in
BCR-mediated signaling pathways involved in cell function (Brunswick et al., 1991;
Panayotou and Waterfield, 1993; Sidorenko et al., 1995). Since PAHs alter B cell
signaling and intracellular Ca2+ homeostasis, it is important to understand the effects of
xenobiotics on PTKs and signal transduction pathways, especially those associated with
Ca2+ signaling in B cells. Therefore, the focus of this chapter is to evaluate the effects of
BaP and certain BaP metabolites on B ceil PTKs, including Lyn and Syk, and to examine
their potential role in alterations in B cell signaling.
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MATERIALS AND METHODS

Monoclonal Antibodies and Reagents. Herbimycin A (Sigma Chemical Co., St.
Louis, MO), BaP, BeP, and the BaP metabolites, benzo(a)pyrene-r-7,/-8-dihydrodiol-f9,10-epoxide(+/-) (anti) (BaP-7,8-diol-9,10-epoxide) and benzo(a)pyrene-trans-7,8dihydrodiol(+/-) (BaP-7,8-diol) (purchased from the NCI Repository, Midwestern
Research Institute, Kansas City, MO) were greater than 95% purity as assessed by the
manufacturer. BaP metabolites and herbimycin A were dissolved in tissue culture grade (>
99% purity) anhydrous dimethylsulfoxide (DMSO; Sigma) which also served as the
solvent control. All compounds were prepared and used under protective yellow light and
visually inspected to affirm that the compounds were completely dissolved in solution.
After BaP metabolites were dissolved in DMSO, the compounds were aliquoted and
stored under nitrogen gas in glass vials at -20° C until use. The final concentration of
DMSO in all cell cultures was < 0.1%. Cultures containing DMSO were analyzed for
biochemical effects and did not differ from controls without DMSO. It was concluded
that at this concentration, DMSO did not produce any measurable effect on intracellular
Ca2+ or PTK responses. For immunoprecipitations, a murine monoclonal antibody to
phosphotyrosine agarose conjugate (Santa Cruz Biotech., Inc., Santa Cruz, CA) was used.
For immunoblots, murine monoclonal antibodies to Lyn (Transduction Laboratories,
Lexington, KY), Syk (4D10), and phosphotyrosine (Santa Cruz) were used. The anti-Syk
(4D10) antibody is a mouse monoclonal IgG^ and reacts with Syk of human origin, and is
noncross-reactive with ZAP-70 or other related protein tyrosine kinases. The anti-Lyn
antibody is a mouse monoclonal IgGi and reacts with Lyn of human, rat, mouse, and chick
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origin. Lyn is often observed as a doublet o f about 56 and 53 kDa that may represent
alternative splicing products o f Lyn mRNA. The anti-phosphotyrosine (PY) antibody as
well as the anti-PY antibody conjugate to agarose, is a mouse monoclonal IgGa, antibody
and reacts with phosphotyrosine-containing proteins and is noncross-reactive with
phosphoserine or phosphothreonine. As a positive control for B cell activation, cells were
stimulated with monoclonal antibody to human IgM at 20 pg/106 cells (g chain; Sigma).
Protease inhibitor cocktail tablets were purchased from Boehringer Mannheim
(Indianapolis, IN) and used at a concentration of 1 tablet/50 mis lysis buffer.
Cell Culturing Conditions o f Daudi cells. Daudi B lymphoblastoid cell line was used
in all experiments and was maintained as described in Chapter 2.
Inhibition o f Protein Tyrosine Kinase (PTK) activity by Herbimycin A. To
determine the potential role o f PTK activity in PAH-induced mobilization of free
intracellular Ca2+, Daudi cells were pretreated with herbimycin A, which inhibits Srcrelated PTKs by irreversibly binding to the sulfhydryl groups of the kinase and depleting
the intracellular level of active enzyme (Knox & Gordon, 1994). Based on previous
studies (Carter et al., 1991), we decided to pretreat cells with Herbimycin A for 18 hours
to achieve optimal PTK inhibition. Cells were pretreated with herbimycin A for 18 hours,
followed by treatment with BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide for 18 hours.
M easurement o f Calcium using Flow Cytometry. Alterations in free intracellular
Ca2+ produced by BaP metabolites were measured using the Ca2+-chelating dyes, Fluo-3
and Fura-Red acetoxymethyl esters (AM) (Molecular Probes, Eugene, OR), and a Coulter
ELITE flow cytometer (Hialeah, FL) as described in the previous chapters. Results are
shown as the change in the Mean Channel Fluo-3/Fura-Red Fluorescence Ratio (MCFR)
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as described in Chapter 1. Cell viability, which ranged from 95% - 99% was determined in
all experiments using trypan blue (Sigma). Thapsigargin (Sigma), was used in all
experiments (1 gM) as a positive control for Ca2+elevation and to ensure that cells and
flow cytometry detection systems were functioning correctly.
Immunoprecipitations and Imm unoblotting. Following treatment with BaP
metabolites or anti-IgM antibody (positive control for B cell activation), cells were
pelleted and resuspended in lysis buffer (1% Nonidet P-40, 150 mM NaCl, 10 mM Tris,
pH 7.5, protease inhibitor cocktail, 2 mM sodium orthovanadate, 0.4 mM EDTA, and 10
mM NaF). Lysates were incubated 15 - 30 minutes on ice and cleared of particulated
nuclear/cytoskeletal components by centrifugation at 15,000 x g for 20 minutes. After
centrifugation, whole cell lysates o f treated Daudi cells were immunoprecipitated using an
anti-PY antibody agarose conjugate overnight at 4° C with constant mixing by rotation.
For standardization purposes, the same amount of protein (2000 pg) in all treatment
groups was added to 40 pi of a 50:50 slurry of anti-PY antibody-conjugated agarose
(stock = 500 pg IgGy/0.25 ml agarose). Following immunoprecipitation, absorbates were
washed three times with lysis buffer, and eluted by resuspension in 200 pi of reducing
SDS-PAGE sample buffer. Either whole cells lysates (30 pg) or PY immunoprecipitates
(50 pi) were boiled 5 minutes and then separated by SDS-PAGE (12%) gels (200 constant
volts for approximately 3 hours) with prestained (rainbow) m.w. markers (BioRad Life
Technologies, Hercules, CA). Size fractionated proteins were then transferred to
polyvinylidene difluoride membranes (PVDF; NEN Research Products, Boston, MA) by
electroblot transfer (Hoefer Scientific Instruments, San Francisco, CA) for 2.5 hours (750
constant amperage).
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Membranes containing transferred proteins were blocked using Tris-buffered saline
(TBS) containing 1% BSA and 1% phosphate-free nonfat dry milk (Upstate
Biotechnology, Lake Placid, NY) overnight at 4° C and subsequently probed with various
antibodies diluted in 1% milk/BSA-TBS for 1 hour at room temperature. These
antibodies included anti-Lyn, anti-Syk, or anti-PY at a dilution of 1:500. Membranes were
then washed 4 times at 10 minutes each with TBS containing 0.05% Triton X-100
(Sigma). Membranes were then incubated for 1 hour with anti-mouse IgG conjugated to
horseradish peroxidase (Santa Cruz) at a dilution of 1:5000 and washed again 4 time at 10
minutes each. Immunoreactive proteins were visualized by an enhanced
chemiluminescence dectection system (NEN Research Products). Syk and Lyn
immunoblots were quantitated using the GS-363 molecular imager system and Molecular
Analyst software (BioRad Life Technologies).
Statistical Design and Analysis. For the Ca2+ elevation studies, sigmaStat statistical
software (Jandel Scientific, San Rafael, CA) was utilized to analyze data for statistical
differences between DMSO control and treated samples analyzed in quadruplicate as
described in Chapter 1. Statistically significant samples were defined asp < 0.05.
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RESULTS

Inhibition o f Protein Tyrosine Kinase (PTK) activity by Herbimycin A. Herbimycin
A was used to determine the potential role of PTK activity in PAH-induced alterations in
Ca2+ homeostasis and immunosuppression. A dose-response for PTK inhibition by
herbimycin A is shown in Figure 19. Daudi cells were pretreated for 18 hours with 0.08,
0.4, or 2 pM herbimycin A followed by treatment with BaP-7,8-diol-9,10-epoxide (3 pM)
for 18 hours. Alone, herbimycin A did not produce a significant Ca2+ response at any of
the concentrations used. Herbimycin A at 0.4 and 2 pM significantly (p < 0.05) reduced
the elevation in intracellular Ca2+ produced by BaP-7,8-diol-9,10-epoxide. Inhibition of
Ca2+ elevation by herbimycin A was greatest at 0.4 pM, and for this reason, this
concentration was used in all subsequent experiments. In Figure 20, second experiment
(representative of 6 separate assays performed) is shown in which herbimycin A
pretreatment significantly (p < 0.05) reduced the Ca2+ elevation produced by both Bap7.8-diol and BaP-7,8-diol-9,10-epoxide. These results suggest that the activation of PTKs
is a necessary step in PAH-induced Ca2+ mobilization. Results are shown as the change in
the MCFR as described in Chapter 1, and values are means for quadruplicate
determinations ± S.D.
B aP Metabolite-Induced Protein Tyrosine Phosphorylation in Daudi Whole cell
lysates. In order to address the role o f PTK activity and the tyrosine phosphorylation
status o f proteins in PAH-induced alterations in intracellular Ca2+, whole cell lysates from
Daudi cells were treated with 10 pM BaP, 10 pM BeP, or 3 pM BaP-7,8-diol and Bap7.8-diol-9, 10-epoxide for 4 hours. These concentrations of PAHs were chosen because
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Figure 19. Dose-response reduction of BaP metabolite-induced intracellular Ca2*
elevation by herbimycin A. Daudi cells were pretreated for 18 hours with the protein
tyrosine kinase inhibitor, herbimycin A, at 0.08, 0.4, or 2 pM concentrations, and then
treated with 3 pM BaP-7,8-diol-9,10-epoxide for 18 hours. Free intracellular Ca2*
was measured by multiparameter flow cytometric analysis using the Ca2*-chelating
dyes Fluo-3 and Fura Red. Results of alterations in intracellular Ca2* concentrations
are shown as the change in the Mean Channel Fluorescence (Fluo-3/Fura Red) Ratio
(MCFR) which is obtained by subtracting the MCFR of DMSO solvent controls from
the MCFR of PAH-treated samples. Values are means for quadruplicate
determinations ± S.D. *Indicates significant (p < 0.05) increase in free intracellular
Ca2+ compared to DMSO vehicle control. §Indicates a significant (p < 0.05) reduction
in intracellular Ca2* by herbimycin A pretreatment compared to BaP-7,8-dioI-9,10epoxide-treatment alone. Actual MCFR of samples having a change in MCFR < 0 is
as follows: DMSO = 215 + 13.1, 0.08 pM herbimycin A = 208 + 4.8, 0.4 pM
herbimycin A = 205 + 4.0, 2 pM herbimycin A = 209 + 2.3.
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Figure 20. Reduction o f BaP-7,8-diol- and BaP-7,8-diol-9,10-epoxide-induced
intracellular Ca2" elevation by herbimycin A. Daudi cells were pretreated for 18 hours
with herbimycin A at a 0.4 pM concentration, and then treated with 3 pM BaP-7,8-diol
BaP-7,8-diol-9,10-epoxide for 18 hours. Free intracellular Ca2+ was measured by
multiparameter flow cytometric analysis using the Ca2+-chelating dyes Fluo-3 and Fura
Red. Results of alterations in intracellular Ca2+ concentrations are shown as the change
the MCFR as previously described. Values are means for quadruplicate determinations
S.D. *Indicates significant (p < 0.05) increase in free intracellular Ca2+ compared to
DMSO vehicle control. §Indicates a significant (p < 0.05) reduction in intracellular Ca2*
herbimycin A pretreatment compared to BaP-7,8-diol or BaP-7,8-dio 1-9,10-epoxidetreatment alone. Actual MCFR of DMSO = 242 + 0.3.
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they were found to be optimal for Ca2+ elevations in Daudi cells. The lysates were
subjected to SDS-PAGE (12 %) electrophoresis, and membranes were then blotted with
murine monoclonal anti-PY antibodies. As shown in Figure 21, both 3 pM BaP-7,8-diol
and BaP-7,8-diol-9,10-epoxide produced an increased tyrosine phosphorylation in proteins
in the 40 kDa and 55-65 kDa size range, which could possibly be Ig-a (34-36 kDa) and
Lyn kinase (56 kDa). PAHs have previously been shown to increase tyrosine
phosphorylation of murine B cell proteins in this same size range (Davila et al., 1995).
These data demonstrate that certain BaP metabolites induce tyrosine phosphorylation of
proteins in human B lymphocytes which may be involved in BCR activation and Ca2+
mobilization.
In Figure 22, Daudi cells were treated for 10 minutes with either anti-IgM antibody
(positive control) or BaP-7,8-diol at 1, 3, and 10 pM concentrations. Whole cell lysates
were subjected to SDS-PAGE and blotted with anti-PY antibody as previously described.
BaP-7,8-diol at all three concentrations stimulated protein tyrosine phosphorylation,
particularly of a protein in the 60 kDa size range. This increased tyrosine phosphorylation
(compared to DMSO control) of the 60 kDa protein was also observed in Daudi cells
treated for 30 minutes (Figure 23). It is possible that this 60 kDa protein may be a Srcfamily kinase, such as Lyn, since it has a molecular weight of 56 kDa.
Increased tyrosine phosphorylation o f Lyn and Syk tyrosine kinases by BaP-7,8-diol
and BaP- 7,S-diol-9,10-epoxide. In order to examine the effects o f BaP metabolites on
the tyrosine phosphorylation o f Syk and Lyn PTKs, whole cell lysates from treated Daudi
cells were immunoprecipitated with anti-PY-conjugated agarose, subjected to SDSPAGE, and then blotted with either anti-Syk or anti-Lyn antibodies. Figure 24 represents
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Figure 21. BaP metabolite-induced protein tyrosine phosphorylation in Daudi whole
cell lysates. Whole cells lysates from Daudi cells treated for 4 hours with either no
treatment (lane 1), 10 pM BaP (lane 2), 10 pM BeP (lane 3), 3 pM BaP-7,8-diol (lane
4) or 3 pM BaP-7,8-diol-9,10-epoxide (lane 5), were subjected to SDS-PAGE
electrophoresis, and membranes were then blotted with monoclonal antibodies to
phosphotyrosine (PY).
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Figure 22. BaP metabolite-induced tyrosine phosphorylation of a protein in the 60 kDa
size range. Whole cells lysates from Daudi cells stimulated for 10 minutes with either antiIgM antibody (positive control, lane 1), DMSO solvent control (lane 2), or BaP-7,8-diol
at I pM (lane 3), 3 pM (lane 4), or lOpM (lane 5), were subjected to SDS-PAGE
electrophoresis, and membranes were then blotted with monoclonal antibodies to
phosphotyrosine.
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Figure 23. BaP metabolite-induced tyrosine phosphorylation of a protein in the 60
kDa size range. Whole cells lysates from Daudi cells stimulated for 30 minutes with
either anti-IgM antibody (positive control, lane 1), DMSO solvent control (lane 2),
or BaP-7,8-diol at 1 pM (lane 3), 3 pM (lane 4), or lOpM (lane 5), were subjected to
SDS-PAGE electrophoresis, and membranes were then blotted with monoclonal
antibodies to phosphotyrosine.
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ANTI-PHOSPIIOTYROSINE IMMUNOBLOT O F WHOLE CELL LYSATES
FROM DAUDI CELLS TREATED FOR 30 MIN

1=
2=
3=
4=
5=

slgM
DMSO
I jiM 7,8-Diol
3 pM 7,8-Diol
10 jiM 7,8-Diol

an immunoblot of Daudi cells treated for 10 minutes. While there was not an observable
dose response between the different concentrations of BaP-7,8-diol-9,10-epoxide, there
was an increase in tyrosine phosphorylation o f Lyn kinase in all treatment groups as
compared to the DMSO solvent control. As shown in Figure 25, the relative signal of Lyn
tyrosine phosphorylation produced by BaP-7,8-diol-9,10-epoxide at 1 pM is 35, which is
more than double the relative signal produced by DMSO control (relative signal = 14).
These numbers were used as relative indicators of signal strength since no statistical
comparisons can be performed on values from single samples. However, the relative
consistency of findings demonstrate that the PAH effects are reproducible and it is known
that a doubling of PTK phosphorylation is biologically relevant (Johnson et al., 1995;
Kurosaki et al., 1995). Lyn kinase is constitutively and transiently phosphorylated and,
therefore, the more than double increase in its tyrosine phosphorylation status produced by
BaP-7,8-diol-9,10-epoxide may also be biologically significant. It is unclear as to why
BaP-7,8-diol-9,10-epoxide at a 3 pM concentration produced a low relative signal of 18.
One possible explanation is that the system is maximally stimulated at this concentration.
However, this is difficult to assume, especially since in cells treated for 30 minutes (Figure
26), the relative signal produced by BaP-7,8-diol-9,10-epoxide at 3 pM is 28, which is
considerably higher than DMSO control which produced a relative signal o f 17 (Figure
27). At 30 minutes, the largest level o f tyrosine phosphorylation is induced by BaP-7,8diol-9,10-epoxide at 1 pM, which produced a relative signal of 32 and is nearly double
compared to DMSO control.
Figure 28 demonstrates that by 18 hours, BaP-7,8-diol-induced tyrosine
phosphorylation of Lyn returned to baseline and was no different from DMSO control.
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Figure 24. Increased tyrosine phosphorylation of Lyn kinase by BaP-7,8-diol-9,10epoxide. Whole cell lysates from treated Daudi cells were immunoprecipitated with
anti-PY-conjugated agarose, subjected to SDS-PAGE, and then blotted with a
monoclonal antibody to Lyn. Daudi cells were treated for 10 minutes with either antiIgM antibody (positive control; lane 1), DMSO solvent control (lane 2), or BaP-7,8diol-9,10-epoxide at 1 pM (lane 3) and 3 pM (lane 4) concentrations.
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Figure 25. The relative signal of Lyn tyrosine phosphorylation produced by BaP-7,8-diol9 ,10-epoxide. Whole cell lysates from Daudi cells treated for 10 minutes were
immunoprecipitated with anti-PY-conjugated agarose and probed with anti-Lyn antibody
as previously described in Figure 24. The relative signal of tyrosine phosphorylation of
Lyn kinase was determined using a molecular imager system. The quantitated relative
signal is o f a single band for each treatment group, and does not represent statistical
analysis.

93 a

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

40

35

Relative Signal

30
25

20
15
10
5
0
oN

jfrJlsP
©<?°

*
6®
« * v
'b'* 0 ^

93b

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 26. Increased tyrosine phosphorylation o f Lyn kinase by BaP-7,8-diol-9,10epoxide. Whole cell lysates from treated Daudi cells were immunoprecipitated with
anti-PY-conjugated agarose, subjected to SDS-PAGE, and then blotted with a
monoclonal antibody to Lyn. Daudi cells were treated for 30 minutes with either antiIgM antibody (positive control; lane 1), DMSO solvent control (lane 2), or BaP-7,8diol-9,10-epoxide at 1 pM (lane 3) and 3 pM (lane 4) concentrations.
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ANTI-LYN IM M UNOBLOT OF PHOSPHOTYROSINE
1MMUNOPREC1P1TATES FROM DAUDI CELLS TREATED FOR 30 MIN

1 = slgM
2 = DMSO
3 = 1 |iM 7,8-Diol Epoxide
4 = 3 fiM 7,8-Diol Epoxide

Figure 27. The relative signal of Lyn tyrosine phosphorylation produced by BaP-7,8diol-9,10-epoxide. Whole cell lysates from Daudi cells treated for 30 minutes were
immunoprecipitated with anti-PY-conjugated agarose and probed with anti-Lyn
antibody as previously described in Figure 26. The relative signal of tyrosine
phosphorylation of Lyn kinase was determined using a molecular imager system. The
quantitated relative signal is of a single band for each treatment group, and does not
represent statistical analysis.
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Figure 28. Tyrosine phosphorylation of Lyn kinase following 18 hours of exposure.
Whole cell lysates from treated Daudi cells were immunoprecipitated with anti-PYconjugated agarose, subjected to SDS-PAGE, and then blotted with a monoclonal
antibody to Lyn. Daudi cells were treated with either DMSO solvent control (lane 1),
or BaP-7,8-diol at 1 pM (lane 2), 3 pM (lane 3), or 10 pM (lane 4) concentrations.
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ANTI-LYN IMMUNOBLOT OF PHOSPHOTYROSINE
IMMUNOPRECIPITATES FROM DAUDI CELLS TREATED FOR 18 HRS

1 = DMSO
2 = 1 fiM 7,8-Diol
3 = 3 jiM 7,8-Diol
4 = 1 0 jiM 7,8-Diol

This return to baseline tyrosine phosphorylation at 18 hours was also observed with BaP7,8-diol-9,10-epoxide and in Syk kinase (data not shown). One possible explanation for
transient increases in tyrosine phosphorylation may be compensatory mechanisms that
regulate phosphorylation levels and PTK activity, such as CD45. Thus, CD45, or other
protein tyrosine phosphatase (PTPase) activity, may lead to dephosphorylation of target
proteins.
At 10 minutes (Figure 29), BaP-7,8-diol-9,10-epoxide also stimulated the tyrosine
phosphorylation o f Syk kinase. While the relative signal of Syk (Figure 30) may not be as
high as seen with BaP-7,8-diol-9,10-epoxide-induced tyrosine phosphorylation of Lyn, it
is difficult to quantitatively compare results obtained from separate experiments. In Daudi
cells treated for 30 minutes, there was no observable increase in tyrosine phosphorylation
of Syk produced by BaP-7,8-diol-9,10-epoxide as compared to DMSO control (data not
shown). Thus, these results demonstrate that tyrosine phosphorylation induced by certain
BaP metabolites is rapid and relatively transient in Daudi human B cells.
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Figure 29. Increased tyrosine phosphorylation of Syk kinase by BaP-7,8-diol-9,10epoxide. Whole cell lysates from treated Daudi cells were immunoprecipitated with antiPY-conjugated agarose, subjected to SDS-PAGE, and then blotted with a monoclonal
antibody to Syk. Daudi cells were treated for 10 minutes with either anti-IgM antibody
(positive control; lane 1), DMSO solvent control (lane 2), or BaP-7,8-diol-9,10-epoxide at
1 pM (lane 3) and 3 pM (lane 4) concentrations.
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Figure 30. The relative signal of Syk tyrosine phosphorylation produced by BaP-7,8diol-9,10-epoxide. Whole cell lysates from Daudi cells treated for 10 minutes were
immunoprecipitated with anti-PY-conjugated agarose and probed with anti-Syk
antibody as previously described in Figure 29. The relative signal of tyrosine
phosphorylation o f Syk kinase was determined using a molecular imager system. The
quantitated relative signal is o f a single band for each treatment group, and does not
represent statistical analysis.
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DISCUSSION

Since previous work in our laboratory has demonstrated that the increase in
intracellular Ca2+ produced by PAHs is likely due to the activation of Src-family protein
tyrosine kinases (Archuleta et al., 1993; Krieger et al., 1994) in T lymphocytes, we
wanted to examine the role of PTKs, particularly Syk and Lyn, in PAH-induced elevations
in intracellular Ca2+ in human B lymphocytes. Past studies have revealed that the
activation of PTKs, such as Syk and Lyn, is an essential step in the propagation of signals
from the BCR to the nucleus, and these activated kinases, in turn, stimulate several
interrelated pathways of signal transduction. For example, immediately following BCR
stimulation and activation o f Syk, PLCyl and 2 are phosphorylated and activated,
resulting in the activation o f protein kinase C (PKC) and the mobilization of Ca2+ from
intracellular stores (Carter et al., 1991; Coggeshall et al., 1992). Additionally, antigen
receptor stimulation and PTK activation leads to the activation of GAP, which regulates
the activity of the ras gene ^21™*) involved in growth control (Panaytou & Waterfield,
1993). A third signaling protein, PI 3-kinase, is activated by direct interaction with Srcfamily kinases, and initiates the activation of other signaling cascades necessary for
proliferation by phosphorylating the inositol ring of inositol phospholipids (Tseng etal.,
1994).
The studies presented in the previous chapters have demonstrated that both BaP-7,8diol and BaP-7,8-diol-9,10-epoxide produce a significant elevation in intracellular Ca2* in
human peripheral blood CD19+B cells. BaP metabolites produce a more potent and rapid
increase in intracellular Ca2+, suggesting that they are ultimately responsible for Ca2*
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elevation. In this chapter, the intracellular Ca2+ elevation produced by BaP-7,8-dioI and
BaP-7,8-dioI-9,10-epoxide was also observed in Daudi human B cells and was
significantly blocked by inhibition of PTKs by herbimycin A. Additionally, exposure to
BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide also resulted in the stimulation of tyrosine
phosphorylation o f Syk and Lyn tyrosine kinases. The same doses of these BaP
metabolites that increased Ca2+ in Daudi also increased tyrosine phosphorylation. These
data suggest that there is a correlation between PTK tyrosine phosphorylation and
intracellular Ca2+ elevations produced by these BaP metabolites. Both Lyn and Syk
kinases are associated with BCR-mediated activation of intracellular signaling pathways
(Ullrich & Schlessinger, 1990; Harwood & Cambier, 1993; van Oers & Weiss, 1995).
Therefore, BaP-induced alterations in the tyrosine phosphorylation status of Lyn and Syk
may be of critical importance in B cell activation and immunotoxicity.
While both BaP-7,8-diol and BaP-7,8-diol-9,10-epoxide produced an increase in
intracellular Ca2+ at longer time points (18 hours) in Daudi cells (Chapter 2), these two
metabolites increased the tyrosine phosphorylation of Lyn and Syk only at shorter
exposure times (10 minutes - 4 hours), but not at 18 hours. Syk couples the BCR to the
phosphatidylinositol/Ca2+ pathway and is associated with BCR-mediated activation of
PLQ2, followed by the generation of IP3 and the subsequent mobilization of intracellular
Ca2+ (Takata et al., 1994; Law era/.; 1996). The BCR-mediated mobilization of free
intracellular Ca2+ occurs immediately following BCR stimulation and is transient
(Premack & Gardner, 1994). Therefore, it is difficult to explain how PTKs maintain Ca2"
elevation at 18 hours when Lyn and Syk tyrosine phosphorylation has returned to baseline.
One possibility is that the rise in intracellular Ca2+ produced by PAHs at the shorter time
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points may be regulated by PTKs while the sustained Ca2+ elevations (> 18 hours) may
involve other mechanisms, such as opening the storage operated Ca2+ channels (SOCC)
located in the plasma membrane of lymphocytes (Premack et al., 1994) or inhibition of
Ca2+ pumps, such as sarcoplasmic/endoplasmic reticulum Ca2* ATPases (SERCA)
(Krieger et al., 1995). Alternatively, PTK activation may continue at low levels or in a
subset of cells at any given time point that cannot be assessed using immunoblot analysis
of the overall population. Since we have not yet determined the cell cycle-dependence of
Ca2+ elevation produced by PAHs, this is another potential source of variability in this
system. Further studies are necessary to resolve these points.
The biochemical mechanisms by which PAHs interact and influence PTK signaling have
not been defined in the present studies. One hypothesis is that the metabolism of BaP
leads to the generation of reactive metabolites, such as BaP-7,8-diol-9,10-epoxide,
capable of reacting with oxidant-sensitive protein sulfhydryls. Reactive oxygen
intermediates (ROI) can readily attack cellular macromolecules directly or by initiating a
chain reaction in which a free radical is passed along macromolecules, resulting in the
damage of cellular components such as plasma membranes and regulatory proteins (Qin et
a l, 1996). Studies have shown that an increase in intracellular Ca2+ and activation of
PTKs, such as Syk, occurs in lymphocytes in response to oxidative stress, including H2O2
treatment and UV radiation (Schievencf al., 1993a, 1993b, 1993c; Yang etal, 1995;
Suzuki et al., 1996). Interestingly, the increase of PTK activity and tyrosine
phosphorylation produced by oxidants has been shown to be indirect resulting from
inhibition of protein tyrosine phosphatase activity (Schieven et al., 1993a; Krejsa et al.,
1997). Our laboratory has recently demonstrated that BaP metabolites produce a
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significant reduction in glutathione (GSH) (Romero et al., 1997), which supports the
current working hypotheses that BaP is metabolized to reactive oxidant species which
could potentially produce a disruption in PTK activation by attacking/oxidizing sulfhydryl
sensitive proteins. Therefore, the metabolism of PAHs by P450, resulting in the
generation of reactive metabolites capable of oxidizing cellular sulfhydryls, may be one
mechanism of PAH-induced PTK dysregulation, alterations in Ca2* homeostasis, and
immunotoxicity. (Gelboin, 1980; Conney et al., 1994; Qin et al., 1996). An alternative
mechanism by which the reactive metabolites of certain PAHs, including BaP-7,8-dioI9 ,10-epoxdie, may interfere with PTK signaling and function is through the covalent
binding amine groups of cellular proteins and peptides (Thakker et al., 1977).
The data presented in this chapter provides some preliminary evidence that PAHs and
particularly the reactive metabolites of PAHs, may modulate intracellular signaling in B
cells through the disruption of PTK activation. The effects of these compounds on other
signaling proteins, however, cannot be excluded. Future studies in our laboratory,
therefore, will focus on the direct effects of PAHs on PTKs as well as other signaling
proteins in human lymphocytes, including the transmembrane tyrosine phosphatase, CD45,
and other protein tyrosine phosphatases.
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GENERAL DISCUSSION

Summary and Conclusions
It is well recognized that, acting as a second messenger, the mobilization of
intracellular Ca2+ is critical in the propagation of signals from external stimuli to the
nucleus. The overall hypothesis that was evaluated in these studies is that polycyclic
aromatic hydrocarbons (PAHs) produce immunotoxicity by altering intracellular Ca2"
homeostasis and Ca2+-dependent signal transduction pathways involved in B cell activation
and function. An extension of this hypothesis is that PAH-induced dismptions in
intracellular Ca2+ homeostasis is associated with cytochrome P450 metabolism and protein
tyrosine kinase activity.
Initial studies examining the mechanism(s) o f PAH-induced immunosuppression
demonstrated that immunotoxic and carcinogenic PAHs, including DMBA, BaP, and 3MC, produce a sustained elevation in intracellular Ca2+ in murine and human T and B
lymphocytes. In employing the very sensitive Ca2"-indicators, Fluo-3 and Fura Red, in
conjunction with PE-conjugated antibodies to cell surface antigens, these studies expanded
on these findings and characterized the differential sensitivity o f normal HPBMC in
surface marker-defined monocytes, B cells, and T cells, to the intracellular Ca2+ changes
produced by PAHs and HAHs. In characterizing PAH-induced elevations in intracellular
Ca2+, most work has been performed in cell lines and until now, the effects of PAHs and
TCDD on intracellular Ca2+ homeostasis has not been evaluated in normal human
monocytes, T lymphocytes, and B lymphocytes.
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These studies showed that PAHs/HAHs produced structure-dependent alterations in
Ca2+ homeostasis in the three different blood cell populations, and the highly immunotoxic
PAHs, DMBA, BaP, and TCDD, compared to BeP and ANTH, two non-immunotoxic
PAHs, produced a structure and time-dependent increase in intracellular Ca2+ in HPBMC.
These data provided information that helps us gain a better understanding of the
mechanism(s) of PAH/HAH-induced immunotoxicity.
The cytochrome P450 inhibition studies demonstrated that elevations in intracellular
Ca2+ produced by BaP in normal human peripheral lymphocytes and monocytes, and by
the BaP metabolite, 7,8-diol in Daudi human B cells, is reduced by ANF, an inhibitor of
cytochrome P450 activity. Additionally, the BaP metabolites, BaP-7,8-diol and BaP-7,8diol-9,10-epoxide were much more effective in producing intracellular Ca2+ elevations
than the parent compound in both Daudi cells and human peripheral blood CD 19* B
lymphocytes. Based on these studies and others, (Ladies et al., 1991; Dipple, 1994), it
appears that the metabolism o f PAHs by cytochrome P450 plays a significant role in PAHinduced intracellular Ca2+ elevation and immunosuppression. While the parent compounds
of certain PAHs, such as DMBA and BaP, do produce alterations in Ca2+ homeostasis in
vitro, these effects may involve both specific and nonspecific components, such as
alterations in plasma membrane or Ca2+ channel activity. The effects of PAH metabolites,
however, may be quite specific, involving reactive oxidants capable of oxidizing cellular
sulfhydryls.
The reactive metabolites/reactive oxygen intermediates generated by P450 metabolism
may readily attack cellular macromolecules resulting in the damage of cellular components
and signaling proteins. Signaling proteins and pathways that may be susceptible to these
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reactive oxidants would include the transmembrane tyrosine phosphatase, CD45, protein
tyrosine kinases, including Syk and Src-family kinases, phospholipase C-y (PLC-y),
protein kinase C (PKC), GTPase activation protein (GAP), phosphatidylinositol 3 kinase
(PI-3 kinase), mitogen activated protein kinase (MAPK), and various transcription factors
involved in growth regulation, including NF-kB and c-Jun (see Figure 31).
Two major signaling pathways important to B lymphocyte activation are protein
tyrosine phosphorylation and intracellular Ca2+ mobilization. Antigen receptor stimulation
results in the activation of protein tyrosine kinases which subsequently leads to the
mobilization of Ca2+ from intracellular stores. Protein tyrosine inhibition by herbimycin A,
a specific protein tyrosine kinase inhibitor, demonstrates that in human B lymphocytes,
there is a strong correlation between protein tyrosine kinase activity and PAH-induced
Ca2+ elevation, and therefore, any dysregulation in protein tyrosine activity produced by
PAHs could ultimately lead to disruptions in Ca2+ homeostasis.
Additionally, immunoblot analysis showed that BaP-7,8-diol and BaP-7,8-diol-9,10epoxide produced an increase in tyrosine phosphorylation o f both Lyn and Syk tyrosine
kinases, and possibly the Ig-a and Ig-p heterodimers. While future studies will focus on
the effects of these compounds on kinase activity in conjunction with increased
autophosphorylation and tyrosine phosphorylation, studies do show that Syk and Lyn
autophosphorylation correlates with and is indicative of increased kinase activity
(DeFranco 1995; Kurosaki et al., 1995; Rowley et al., 1995).
Future Studies
Evaluating and characterizing the mechanisms by which PAHs exert their
immunosuppressive effects in lymphoid cells will help us gain a better understanding of
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Figure 31. B cell antigen receptor (BCR)-mediated signal transduction pathways. The
BCR is noncovalently associated with disulfide-linked heterodimers, Ig-a and Ig-P, which
play an important role in BCR-mediated signaling pathways. Several protein tyrosine
kinases, including Syk and Src-family kinases, such as Lyn, are associated with the Ig-a
and Ig-P proteins. The tyrosine transmembrane phosphatase, CD45, activates Src-family
kinases through the dephosphorylation of a specific tyrosine residue in the negative
regulatory C-terminal domain. B cell antigen crosslinking activates Src and Syk kinases
which subsequently results in the generation important second messengers, including Ca2\
diacylglycerol (DAG), and inositol triphosphate (IP3). The activation of various signaling
cascades leads to the activation of transcription factors that stimulate the transcription of
specific genes. From: Kuby, J. (1997). Immunology 3rdEdition, Figure 8-8, p. 204, with
permission.
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important health effects of PAHs on human immune function and may provide meaningful
insight in identifying important genetic factors, such as polymorphisms, associated with
PAH-induced immunotoxicity.
There are several other postulated mechanisms by which PAHs produce dysregulation
in Ca2+ homeostasis and cell signaling not examined in these studies, and will be evaluated
in the future. One area of focus will examine the potential influence of PAHs on Ca2*
influx associated with storage-operated Ca2+ channels (SOCC) in human T and B
lymphocytes. Second, our laboratory will further characterize the inhibitory effects of
PAHs and certain BaP metabolites on human sarcoplasmic/endoplasmic reticulum calcium
ATPases (SERCA), which actively pumps cytosolic Ca2+ back into the endoplasmic
reticulum (Krieger et al., 1995).
These and past studies performed in our laboratory have demonstrated that the
elevation in intracellular Ca2+ produced by PAHs and certain BaP metabolites strongly
correlates with, and is likely due to the dysregulation and activation of protein tyrosine
kinases. Using an in vitro kinase activity assay, future studies will examine the effects of
these compounds on Syk/ZAP-70 and Src-family kinase, including Lyn, activity in human
T and B cells, as well as characterize whether the effects of PAHs on kinase activity is
direct or indirect. PAHs may activate protein tyrosine kinases indirectly by inhibiting
phosphatases, and for this reason, we will also evaluate the effects of PAHs and specific
BaP metabolites on the tyrosine phosphatase, CD45. CD45 selectively associates and
regulates Lyn kinase activity (Brown et al., 1994; Katagiri et al., 1995), and has been
shown to be sensitive to oxidative stress (Schieven et al., 1994).

108

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Future work will continue to further evaluate the role of cytochrome P450 metabolism,
as well as characterize the role of the aryl-hydrocarbon receptor (AhR) in PAH signaling
and immunotoxicity. It is likely a combination of biochemical mechanisms and interrelated
signaling cascades crosstalk with Ca2+ pathways and are responsible for the immunotoxic
effects mediated by PAHs. Future work focusing on the molecular mechanisms
responsible for PAH immunosuppression, therefore, will help us gain a more complete
understanding o f PAH-induced immunotoxicity and potential environmental risk factors
associated with PAH suppression of human immune function.
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ABBREVIATIONS

AhR

aryl-hydrocarbon receptor

ANF

a-naphthoflavone

ANTH

anthracene

BA

benz(a)anthracene

BaP

benzo(a)pyrene

BaP-7,8-diol

benzo(a)pyrene-trans-7,8-dihydrodiol (±)

BaP-7,8-diol9,10-epoxide

benzo(a)pyrene-r-7,t-8-dihydrodiol-t-9,10-epoxide (+), (anti)

BCR

B cell receptor

BeP

benzo(e)pyrene

Con A

concanavalin A

DAG

diacylglycerol

DMA

9,10-dimethylanthracene

DMBA

7 ,12-dimethylbenz(a)anthracene

DMSO

dimethylsulfoxide

GAP

GTPase-activating protein

HAH

halogenated aromatic hydrocarbon

HPBMC

human peripheral mononuclear cell

IgG

immunoglobulin G

IgM

immunoglobulin M

IPs

inositol 1,4,5-trisphosphate
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ITAM

immunoreceptor tyrosine based activation motif

MAPK

mitogen-activated protein kinase

MCFR

mean channel fluorescence ratio

PAH(s)

polycyclic aromatic hydrocarbon(s)

PE

phycoerythrin

PHA

phytohemagglutinin

PI 3-kinase

phosphoinositide 3-kinase

PLC

phospholipase C

PTK

protein tyrosine kinase

SERCA

sarcoplasmic/endoplasmic reticulum calcium ATPase

SH2/SH 3

Src-homology domain

SRBC

sheep red blood cell

TCDD

2,3,7,8 -tetrachlorodibenzo(p)dioxin

TCR

T cell receptor

3-MC

3-methylcholanthrene
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